id	sid	tid	token	lemma	pos
ijpds-4052	1	1	bhui	bhui	PROPN
ijpds-4052	1	2	u	u	PROPN
ijpds-4052	1	3	et	et	PROPN
ijpds-4052	1	4	al	al	PROPN
ijpds-4052	1	5	.	.	PUNCT
ijpds-4052	1	6	anti	anti	ADJ
ijpds-4052	1	7	-	-	ADJ
ijpds-4052	1	8	tubercular	tubercular	ADJ
ijpds-4052	1	9	drug	drug	NOUN
ijpds-4052	1	10	-	-	PUNCT
ijpds-4052	1	11	induced	induce	VERB
ijpds-4052	1	12	vitamin	vitamin	NOUN
ijpds-4052	1	13	b6	b6	NOUN
ijpds-4052	1	14	deficiency	deficiency	NOUN
ijpds-4052	1	15	vol	vol	NOUN
ijpds-4052	1	16	2	2	NUM
ijpds-4052	1	17	|	|	NOUN
ijpds-4052	1	18	issue	issue	VERB
ijpds-4052	1	19	3	3	NUM
ijpds-4052	1	20	|	|	ADV
ijpds-4052	1	21	jul	jul	PROPN
ijpds-4052	1	22	–	–	PUNCT
ijpds-4052	1	23	sep	sep	PROPN
ijpds-4052	1	24	2023	2023	NUM
ijpds-4052	1	25	indian	indian	PROPN
ijpds-4052	1	26	j	j	PROPN
ijpds-4052	1	27	pharm	pharm	PROPN
ijpds-4052	1	28	drug	drug	PROPN
ijpds-4052	1	29	studies	study	NOUN
ijpds-4052	1	30	|	|	ADV
ijpds-4052	1	31	124	124	NUM
ijpds-4052	1	32	case	case	NOUN
ijpds-4052	1	33	report	report	NOUN
ijpds-4052	1	34	unraveling	unravel	VERB
ijpds-4052	1	35	the	the	DET
ijpds-4052	1	36	enigma	enigma	NOUN
ijpds-4052	1	37	of	of	ADP
ijpds-4052	1	38	anti	anti	ADJ
ijpds-4052	1	39	-	-	ADJ
ijpds-4052	1	40	tubercular	tubercular	ADJ
ijpds-4052	1	41	drug	drug	NOUN
ijpds-4052	1	42	-	-	PUNCT
ijpds-4052	1	43	induced	induce	VERB
ijpds-4052	1	44	vitamin	vitamin	NOUN
ijpds-4052	1	45	b6	b6	NOUN
ijpds-4052	1	46	deficiency	deficiency	NOUN
ijpds-4052	1	47	and	and	CCONJ
ijpds-4052	1	48	its	its	PRON
ijpds-4052	1	49	role	role	NOUN
ijpds-4052	1	50	in	in	ADP
ijpds-4052	1	51	provoking	provoke	VERB
ijpds-4052	1	52	convulsive	convulsive	ADJ
ijpds-4052	1	53	seizures	seizure	NOUN
ijpds-4052	1	54	a	a	DET
ijpds-4052	1	55	revelatory	revelatory	ADJ
ijpds-4052	1	56	case	case	NOUN
ijpds-4052	1	57	report	report	NOUN
ijpds-4052	1	58	utpal	utpal	NOUN
ijpds-4052	1	59	bhui1	bhui1	PROPN
ijpds-4052	1	60	,	,	PUNCT
ijpds-4052	1	61	subhajit	subhajit	NOUN
ijpds-4052	1	62	sarkar1	sarkar1	PROPN
ijpds-4052	1	63	,	,	PUNCT
ijpds-4052	1	64	joy	joy	NOUN
ijpds-4052	1	65	das1	das1	NOUN
ijpds-4052	1	66	,	,	PUNCT
ijpds-4052	1	67	indra	indra	PROPN
ijpds-4052	1	68	kumar	kumar	PROPN
ijpds-4052	1	69	ghoshal1	ghoshal1	PROPN
ijpds-4052	1	70	,	,	PUNCT
ijpds-4052	1	71	abhik	abhik	NOUN
ijpds-4052	1	72	saha2	saha2	NOUN
ijpds-4052	1	73	,	,	PUNCT
ijpds-4052	1	74	bimlesh	bimlesh	PROPN
ijpds-4052	1	75	kumar3	kumar3	NOUN
ijpds-4052	1	76	from	from	ADP
ijpds-4052	1	77	,	,	PUNCT
ijpds-4052	1	78	1pg	1pg	ADJ
ijpds-4052	1	79	student	student	NOUN
ijpds-4052	1	80	,	,	PUNCT
ijpds-4052	1	81	school	school	NOUN
ijpds-4052	1	82	of	of	ADP
ijpds-4052	1	83	pharmaceutical	pharmaceutical	NOUN
ijpds-4052	1	84	sciences	science	NOUN
ijpds-4052	1	85	,	,	PUNCT
ijpds-4052	1	86	lovely	lovely	ADJ
ijpds-4052	1	87	professional	professional	ADJ
ijpds-4052	1	88	university	university	NOUN
ijpds-4052	1	89	,	,	PUNCT
ijpds-4052	1	90	phagwara	phagwara	ADJ
ijpds-4052	1	91	,	,	PUNCT
ijpds-4052	1	92	punjab	punjab	ADJ
ijpds-4052	1	93	,	,	PUNCT
ijpds-4052	1	94	2pharmacovigilance	2pharmacovigilance	NUM
ijpds-4052	1	95	associate	associate	NOUN
ijpds-4052	1	96	,	,	PUNCT
ijpds-4052	2	1	r.	r.	PROPN
ijpds-4052	2	2	g.	g.	PROPN
ijpds-4052	2	3	kar	kar	PROPN
ijpds-4052	2	4	medical	medical	PROPN
ijpds-4052	2	5	college	college	PROPN
ijpds-4052	2	6	,	,	PUNCT
ijpds-4052	2	7	kolkata	kolkata	PROPN
ijpds-4052	2	8	,	,	PUNCT
ijpds-4052	2	9	west	west	PROPN
ijpds-4052	2	10	bengal	bengal	PROPN
ijpds-4052	2	11	,	,	PUNCT
ijpds-4052	2	12	3professor	3professor	NUM
ijpds-4052	2	13	,	,	PUNCT
ijpds-4052	2	14	department	department	NOUN
ijpds-4052	2	15	of	of	ADP
ijpds-4052	2	16	pharmacology	pharmacology	NOUN
ijpds-4052	2	17	,	,	PUNCT
ijpds-4052	2	18	school	school	NOUN
ijpds-4052	2	19	of	of	ADP
ijpds-4052	2	20	pharmaceutical	pharmaceutical	NOUN
ijpds-4052	2	21	sciences	science	NOUN
ijpds-4052	2	22	,	,	PUNCT
ijpds-4052	2	23	lovely	lovely	ADJ
ijpds-4052	2	24	professional	professional	ADJ
ijpds-4052	2	25	university	university	NOUN
ijpds-4052	2	26	,	,	PUNCT
ijpds-4052	2	27	phagwara	phagwara	ADJ
ijpds-4052	2	28	,	,	PUNCT
ijpds-4052	2	29	punjab	punjab	PROPN
ijpds-4052	2	30	,	,	PUNCT
ijpds-4052	2	31	india	india	PROPN
ijpds-4052	2	32	.	.	PUNCT
ijpds-4052	3	1	abstract	abstract	ADP
ijpds-4052	3	2	the	the	DET
ijpds-4052	3	3	65	65	NUM
ijpds-4052	3	4	-	-	PUNCT
ijpds-4052	3	5	year	year	NOUN
ijpds-4052	3	6	-	-	PUNCT
ijpds-4052	3	7	old	old	ADJ
ijpds-4052	3	8	female	female	ADJ
ijpds-4052	3	9	patient	patient	NOUN
ijpds-4052	3	10	with	with	ADP
ijpds-4052	3	11	active	active	ADJ
ijpds-4052	3	12	tuberculosis	tuberculosis	NOUN
ijpds-4052	3	13	who	who	PRON
ijpds-4052	3	14	was	be	AUX
ijpds-4052	3	15	hospitalized	hospitalize	VERB
ijpds-4052	3	16	to	to	ADP
ijpds-4052	3	17	the	the	DET
ijpds-4052	3	18	primary	primary	ADJ
ijpds-4052	3	19	hospital	hospital	NOUN
ijpds-4052	3	20	and	and	CCONJ
ijpds-4052	3	21	was	be	AUX
ijpds-4052	3	22	on	on	ADP
ijpds-4052	3	23	category	category	NOUN
ijpds-4052	3	24	1	1	NUM
ijpds-4052	3	25	antitubercular	antitubercular	ADJ
ijpds-4052	3	26	drugs	drug	NOUN
ijpds-4052	3	27	(	(	PUNCT
ijpds-4052	3	28	cat	cat	NOUN
ijpds-4052	3	29	1	1	NUM
ijpds-4052	3	30	atd	atd	NOUN
ijpds-4052	3	31	)	)	PUNCT
ijpds-4052	3	32	is	be	AUX
ijpds-4052	3	33	the	the	DET
ijpds-4052	3	34	subject	subject	NOUN
ijpds-4052	3	35	of	of	ADP
ijpds-4052	3	36	this	this	DET
ijpds-4052	3	37	case	case	NOUN
ijpds-4052	3	38	report	report	NOUN
ijpds-4052	3	39	.	.	PUNCT
ijpds-4052	4	1	the	the	DET
ijpds-4052	4	2	patient	patient	NOUN
ijpds-4052	4	3	had	have	VERB
ijpds-4052	4	4	complications	complication	NOUN
ijpds-4052	4	5	,	,	PUNCT
ijpds-4052	4	6	a	a	DET
ijpds-4052	4	7	reduced	reduced	ADJ
ijpds-4052	4	8	appetite	appetite	NOUN
ijpds-4052	4	9	,	,	PUNCT
ijpds-4052	4	10	had	have	AUX
ijpds-4052	4	11	stopped	stop	VERB
ijpds-4052	4	12	eating	eat	VERB
ijpds-4052	4	13	,	,	PUNCT
ijpds-4052	4	14	was	be	AUX
ijpds-4052	4	15	nauseous	nauseous	ADJ
ijpds-4052	4	16	,	,	PUNCT
ijpds-4052	4	17	and	and	CCONJ
ijpds-4052	4	18	had	have	AUX
ijpds-4052	4	19	vomited	vomit	VERB
ijpds-4052	4	20	.	.	PUNCT
ijpds-4052	5	1	eight	eight	NUM
ijpds-4052	5	2	months	month	NOUN
ijpds-4052	5	3	prior	prior	ADV
ijpds-4052	5	4	,	,	PUNCT
ijpds-4052	5	5	the	the	DET
ijpds-4052	5	6	patient	patient	NOUN
ijpds-4052	5	7	has	have	AUX
ijpds-4052	5	8	prescribed	prescribe	VERB
ijpds-4052	5	9	the	the	DET
ijpds-4052	5	10	first	first	ADJ
ijpds-4052	5	11	-	-	PUNCT
ijpds-4052	5	12	line	line	NOUN
ijpds-4052	5	13	anti	anti	ADJ
ijpds-4052	5	14	-	-	ADJ
ijpds-4052	5	15	tubercular	tubercular	ADJ
ijpds-4052	5	16	medications	medication	NOUN
ijpds-4052	5	17	rifampin	rifampin	NOUN
ijpds-4052	5	18	,	,	PUNCT
ijpds-4052	5	19	rifabutin	rifabutin	NOUN
ijpds-4052	5	20	,	,	PUNCT
ijpds-4052	5	21	ethambutol	ethambutol	ADJ
ijpds-4052	5	22	,	,	PUNCT
ijpds-4052	5	23	and	and	CCONJ
ijpds-4052	5	24	isoniazid	isoniazid	NOUN
ijpds-4052	5	25	.	.	PUNCT
ijpds-4052	6	1	three	three	NUM
ijpds-4052	6	2	months	month	NOUN
ijpds-4052	6	3	prior	prior	ADV
ijpds-4052	6	4	,	,	PUNCT
ijpds-4052	6	5	the	the	DET
ijpds-4052	6	6	patient	patient	NOUN
ijpds-4052	6	7	stopped	stop	VERB
ijpds-4052	6	8	taking	take	VERB
ijpds-4052	6	9	the	the	DET
ijpds-4052	6	10	medicine	medicine	NOUN
ijpds-4052	6	11	.	.	PUNCT
ijpds-4052	7	1	now	now	ADV
ijpds-4052	7	2	,	,	PUNCT
ijpds-4052	7	3	as	as	ADP
ijpds-4052	7	4	a	a	DET
ijpds-4052	7	5	result	result	NOUN
ijpds-4052	7	6	of	of	ADP
ijpds-4052	7	7	an	an	DET
ijpds-4052	7	8	unfavorable	unfavorable	ADJ
ijpds-4052	7	9	drug	drug	NOUN
ijpds-4052	7	10	reaction	reaction	NOUN
ijpds-4052	7	11	to	to	ADP
ijpds-4052	7	12	anti	anti	ADJ
ijpds-4052	7	13	-	-	ADJ
ijpds-4052	7	14	tubercular	tubercular	ADJ
ijpds-4052	7	15	medications	medication	NOUN
ijpds-4052	7	16	,	,	PUNCT
ijpds-4052	7	17	the	the	DET
ijpds-4052	7	18	patient	patient	NOUN
ijpds-4052	7	19	had	have	AUX
ijpds-4052	7	20	acquired	acquire	VERB
ijpds-4052	7	21	acute	acute	ADJ
ijpds-4052	7	22	hepatitis	hepatitis	NOUN
ijpds-4052	7	23	and	and	CCONJ
ijpds-4052	7	24	convulsive	convulsive	ADJ
ijpds-4052	7	25	seizuresdue	seizuresdue	NOUN
ijpds-4052	7	26	to	to	ADP
ijpds-4052	7	27	vitamin	vitamin	NOUN
ijpds-4052	7	28	b6	b6	NOUN
ijpds-4052	7	29	deficiency	deficiency	NOUN
ijpds-4052	7	30	.	.	PUNCT
ijpds-4052	8	1	key	key	ADJ
ijpds-4052	8	2	words	word	NOUN
ijpds-4052	8	3	:	:	PUNCT
ijpds-4052	8	4	cat	cat	NOUN
ijpds-4052	8	5	1	1	NUM
ijpds-4052	8	6	atd	atd	PROPN
ijpds-4052	8	7	,	,	PUNCT
ijpds-4052	8	8	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	8	9	,	,	PUNCT
ijpds-4052	8	10	convulsion	convulsion	NOUN
ijpds-4052	8	11	,	,	PUNCT
ijpds-4052	8	12	tuberculosis	tuberculosis	NOUN
ijpds-4052	8	13	,	,	PUNCT
ijpds-4052	8	14	vitamin	vitamin	NOUN
ijpds-4052	8	15	deficiency	deficiency	NOUN
ijpds-4052	8	16	,	,	PUNCT
ijpds-4052	8	17	drug	drug	NOUN
ijpds-4052	8	18	-	-	PUNCT
ijpds-4052	8	19	drug	drug	NOUN
ijpds-4052	8	20	interaction	interaction	NOUN
ijpds-4052	8	21	,	,	PUNCT
ijpds-4052	8	22	adverse	adverse	ADJ
ijpds-4052	8	23	drug	drug	NOUN
ijpds-4052	8	24	reaction	reaction	NOUN
ijpds-4052	8	25	.	.	PUNCT
ijpds-4052	9	1	ycobacterium	ycobacterium	NOUN
ijpds-4052	9	2	tuberculosis	tuberculosis	NOUN
ijpds-4052	9	3	,	,	PUNCT
ijpds-4052	9	4	which	which	PRON
ijpds-4052	9	5	induces	induce	VERB
ijpds-4052	9	6	tuberculosis	tuberculosis	NOUN
ijpds-4052	9	7	(	(	PUNCT
ijpds-4052	9	8	tb	tb	NOUN
ijpds-4052	9	9	)	)	PUNCT
ijpds-4052	9	10	,	,	PUNCT
ijpds-4052	9	11	is	be	AUX
ijpds-4052	9	12	a	a	DET
ijpds-4052	9	13	potentially	potentially	ADV
ijpds-4052	9	14	serious	serious	ADJ
ijpds-4052	9	15	infectious	infectious	ADJ
ijpds-4052	9	16	bacterial	bacterial	ADJ
ijpds-4052	9	17	disease	disease	NOUN
ijpds-4052	9	18	that	that	PRON
ijpds-4052	9	19	primarily	primarily	ADV
ijpds-4052	9	20	affects	affect	VERB
ijpds-4052	9	21	the	the	DET
ijpds-4052	9	22	lungs	lung	NOUN
ijpds-4052	9	23	.	.	PUNCT
ijpds-4052	10	1	this	this	DET
ijpds-4052	10	2	illness	illness	NOUN
ijpds-4052	10	3	spreads	spread	VERB
ijpds-4052	10	4	when	when	SCONJ
ijpds-4052	10	5	a	a	DET
ijpds-4052	10	6	person	person	NOUN
ijpds-4052	10	7	inhales	inhale	VERB
ijpds-4052	10	8	sputum	sputum	NOUN
ijpds-4052	10	9	splashes	splash	NOUN
ijpds-4052	10	10	that	that	PRON
ijpds-4052	10	11	enter	enter	VERB
ijpds-4052	10	12	through	through	ADP
ijpds-4052	10	13	the	the	DET
ijpds-4052	10	14	mouth	mouth	NOUN
ijpds-4052	10	15	and	and	CCONJ
ijpds-4052	10	16	nose	nose	NOUN
ijpds-4052	10	17	,	,	PUNCT
ijpds-4052	10	18	upper	upper	ADJ
ijpds-4052	10	19	respiratory	respiratory	ADJ
ijpds-4052	10	20	tract	tract	NOUN
ijpds-4052	10	21	,	,	PUNCT
ijpds-4052	10	22	and	and	CCONJ
ijpds-4052	10	23	bronchi	bronchi	NOUN
ijpds-4052	10	24	before	before	ADP
ijpds-4052	10	25	reaching	reach	VERB
ijpds-4052	10	26	the	the	DET
ijpds-4052	10	27	lungs	lung	NOUN
ijpds-4052	10	28	'	'	PART
ijpds-4052	10	29	alveoli	alveoli	NOUN
ijpds-4052	10	30	and	and	CCONJ
ijpds-4052	10	31	potentially	potentially	ADV
ijpds-4052	10	32	attacking	attack	VERB
ijpds-4052	10	33	internal	internal	ADJ
ijpds-4052	10	34	organs	organ	NOUN
ijpds-4052	10	35	.	.	PUNCT
ijpds-4052	11	1	the	the	DET
ijpds-4052	11	2	bacteria	bacteria	NOUN
ijpds-4052	11	3	that	that	PRON
ijpds-4052	11	4	cause	cause	VERB
ijpds-4052	11	5	tuberculosis	tuberculosis	NOUN
ijpds-4052	11	6	can	can	AUX
ijpds-4052	11	7	infect	infect	VERB
ijpds-4052	11	8	a	a	DET
ijpds-4052	11	9	lot	lot	NOUN
ijpds-4052	11	10	of	of	ADP
ijpds-4052	11	11	people	people	NOUN
ijpds-4052	11	12	without	without	ADP
ijpds-4052	11	13	any	any	DET
ijpds-4052	11	14	symptoms	symptom	NOUN
ijpds-4052	11	15	.	.	PUNCT
ijpds-4052	12	1	the	the	DET
ijpds-4052	12	2	most	most	ADV
ijpds-4052	12	3	typical	typical	ADJ
ijpds-4052	12	4	signs	sign	NOUN
ijpds-4052	12	5	of	of	ADP
ijpds-4052	12	6	this	this	PRON
ijpds-4052	12	7	are	be	AUX
ijpds-4052	12	8	fever	fever	NOUN
ijpds-4052	12	9	,	,	PUNCT
ijpds-4052	12	10	weight	weight	NOUN
ijpds-4052	12	11	loss	loss	NOUN
ijpds-4052	12	12	,	,	PUNCT
ijpds-4052	12	13	night	night	NOUN
ijpds-4052	12	14	sweats	sweat	NOUN
ijpds-4052	12	15	,	,	PUNCT
ijpds-4052	12	16	and	and	CCONJ
ijpds-4052	12	17	coughing	cough	VERB
ijpds-4052	12	18	that	that	PRON
ijpds-4052	12	19	occasionally	occasionally	ADV
ijpds-4052	12	20	has	have	VERB
ijpds-4052	12	21	a	a	DET
ijpds-4052	12	22	bloody	bloody	ADJ
ijpds-4052	12	23	tint	tint	NOUN
ijpds-4052	13	1	[	[	X
ijpds-4052	13	2	1].as	1].as	NUM
ijpds-4052	13	3	a	a	DET
ijpds-4052	13	4	result	result	NOUN
ijpds-4052	13	5	,	,	PUNCT
ijpds-4052	13	6	even	even	ADV
ijpds-4052	13	7	if	if	SCONJ
ijpds-4052	13	8	effective	effective	ADJ
ijpds-4052	13	9	chemotherapy	chemotherapy	NOUN
ijpds-4052	13	10	is	be	AUX
ijpds-4052	13	11	available	available	ADJ
ijpds-4052	13	12	,	,	PUNCT
ijpds-4052	13	13	tb	tb	X
ijpds-4052	13	14	remains	remain	VERB
ijpds-4052	13	15	a	a	DET
ijpds-4052	13	16	serious	serious	ADJ
ijpds-4052	13	17	health	health	NOUN
ijpds-4052	13	18	concern	concern	NOUN
ijpds-4052	13	19	in	in	ADP
ijpds-4052	13	20	the	the	DET
ijpds-4052	13	21	majority	majority	NOUN
ijpds-4052	13	22	of	of	ADP
ijpds-4052	13	23	countries	country	NOUN
ijpds-4052	13	24	.	.	PUNCT
ijpds-4052	14	1	this	this	PRON
ijpds-4052	14	2	is	be	AUX
ijpds-4052	14	3	owing	owe	VERB
ijpds-4052	14	4	to	to	ADP
ijpds-4052	14	5	low	low	ADJ
ijpds-4052	14	6	patient	patient	NOUN
ijpds-4052	14	7	adherence	adherence	NOUN
ijpds-4052	14	8	,	,	PUNCT
ijpds-4052	14	9	primary	primary	ADJ
ijpds-4052	14	10	multidrug	multidrug	NOUN
ijpds-4052	14	11	resistance	resistance	NOUN
ijpds-4052	14	12	,	,	PUNCT
ijpds-4052	14	13	and	and	CCONJ
ijpds-4052	14	14	interruptions	interruption	NOUN
ijpds-4052	14	15	partly	partly	ADV
ijpds-4052	14	16	brought	bring	VERB
ijpds-4052	14	17	on	on	ADP
ijpds-4052	14	18	by	by	ADP
ijpds-4052	14	19	adverse	adverse	ADJ
ijpds-4052	14	20	drug	drug	NOUN
ijpds-4052	14	21	reactions	reaction	NOUN
ijpds-4052	14	22	(	(	PUNCT
ijpds-4052	14	23	adrs	adrs	PROPN
ijpds-4052	14	24	)	)	PUNCT
ijpds-4052	14	25	.	.	PUNCT
ijpds-4052	15	1	as	as	ADP
ijpds-4052	15	2	a	a	DET
ijpds-4052	15	3	result	result	NOUN
ijpds-4052	15	4	,	,	PUNCT
ijpds-4052	15	5	more	more	ADV
ijpds-4052	15	6	resistant	resistant	ADJ
ijpds-4052	15	7	strains	strain	NOUN
ijpds-4052	15	8	evolve	evolve	VERB
ijpds-4052	15	9	,	,	PUNCT
ijpds-4052	15	10	necessitating	necessitate	VERB
ijpds-4052	15	11	second	second	ADJ
ijpds-4052	15	12	-	-	PUNCT
ijpds-4052	15	13	line	line	NOUN
ijpds-4052	15	14	therapy	therapy	NOUN
ijpds-4052	15	15	with	with	ADP
ijpds-4052	15	16	more	more	ADV
ijpds-4052	15	17	expensive	expensive	ADJ
ijpds-4052	15	18	medications	medication	NOUN
ijpds-4052	15	19	and	and	CCONJ
ijpds-4052	15	20	significant	significant	ADJ
ijpds-4052	15	21	adrs	adr	NOUN
ijpds-4052	15	22	.	.	PUNCT
ijpds-4052	16	1	access	access	NOUN
ijpds-4052	16	2	this	this	DET
ijpds-4052	16	3	article	article	NOUN
ijpds-4052	16	4	online	online	ADV
ijpds-4052	16	5	received	receive	VERB
ijpds-4052	16	6	–	–	PUNCT
ijpds-4052	16	7	20th	20th	ADJ
ijpds-4052	16	8	may	may	AUX
ijpds-4052	16	9	2023	2023	NUM
ijpds-4052	16	10	initial	initial	ADJ
ijpds-4052	16	11	review	review	NOUN
ijpds-4052	16	12	–	–	PUNCT
ijpds-4052	16	13	29th	29th	NOUN
ijpds-4052	16	14	may	may	AUX
ijpds-4052	16	15	2023	2023	NUM
ijpds-4052	16	16	accepted	accept	VERB
ijpds-4052	16	17	–	–	PUNCT
ijpds-4052	16	18	1st	1st	ADJ
ijpds-4052	16	19	june	june	PROPN
ijpds-4052	16	20	2023	2023	NUM
ijpds-4052	16	21	quick	quick	ADJ
ijpds-4052	16	22	response	response	NOUN
ijpds-4052	16	23	code	code	NOUN
ijpds-4052	16	24	adrs	adr	NOUN
ijpds-4052	16	25	significantly	significantly	ADV
ijpds-4052	16	26	increase	increase	VERB
ijpds-4052	16	27	patient	patient	ADJ
ijpds-4052	16	28	morbidity	morbidity	NOUN
ijpds-4052	16	29	and	and	CCONJ
ijpds-4052	16	30	mortality	mortality	NOUN
ijpds-4052	16	31	,	,	PUNCT
ijpds-4052	16	32	which	which	PRON
ijpds-4052	16	33	drives	drive	VERB
ijpds-4052	16	34	up	up	ADP
ijpds-4052	16	35	healthcare	healthcare	NOUN
ijpds-4052	16	36	costs	cost	NOUN
ijpds-4052	16	37	and	and	CCONJ
ijpds-4052	16	38	is	be	AUX
ijpds-4052	16	39	a	a	DET
ijpds-4052	16	40	major	major	ADJ
ijpds-4052	16	41	issue	issue	NOUN
ijpds-4052	16	42	for	for	ADP
ijpds-4052	16	43	the	the	DET
ijpds-4052	16	44	common	common	ADJ
ijpds-4052	16	45	people	people	NOUN
ijpds-4052	16	46	,	,	PUNCT
ijpds-4052	16	47	the	the	DET
ijpds-4052	16	48	pharmaceutical	pharmaceutical	NOUN
ijpds-4052	16	49	industry	industry	NOUN
ijpds-4052	16	50	,	,	PUNCT
ijpds-4052	16	51	regulatory	regulatory	ADJ
ijpds-4052	16	52	agencies	agency	NOUN
ijpds-4052	16	53	,	,	PUNCT
ijpds-4052	16	54	and	and	CCONJ
ijpds-4052	16	55	the	the	DET
ijpds-4052	16	56	medical	medical	ADJ
ijpds-4052	16	57	community	community	NOUN
ijpds-4052	17	1	[	[	X
ijpds-4052	17	2	2].depending	2].depende	VERB
ijpds-4052	17	3	on	on	ADP
ijpds-4052	17	4	the	the	DET
ijpds-4052	17	5	severity	severity	NOUN
ijpds-4052	17	6	of	of	ADP
ijpds-4052	17	7	the	the	DET
ijpds-4052	17	8	condition	condition	NOUN
ijpds-4052	17	9	,	,	PUNCT
ijpds-4052	17	10	taking	take	VERB
ijpds-4052	17	11	medicine	medicine	NOUN
ijpds-4052	17	12	for	for	ADP
ijpds-4052	17	13	tb	tb	NOUN
ijpds-4052	17	14	might	might	AUX
ijpds-4052	17	15	last	last	VERB
ijpds-4052	17	16	between	between	ADP
ijpds-4052	17	17	6	6	NUM
ijpds-4052	17	18	and	and	CCONJ
ijpds-4052	17	19	9	9	NUM
ijpds-4052	17	20	months	month	NOUN
ijpds-4052	17	21	.	.	PUNCT
ijpds-4052	18	1	the	the	DET
ijpds-4052	18	2	united	united	PROPN
ijpds-4052	18	3	states	states	PROPN
ijpds-4052	18	4	food	food	PROPN
ijpds-4052	18	5	and	and	CCONJ
ijpds-4052	18	6	drug	drug	PROPN
ijpds-4052	18	7	administration	administration	PROPN
ijpds-4052	18	8	(	(	PUNCT
ijpds-4052	18	9	usfda	usfda	PROPN
ijpds-4052	18	10	)	)	PUNCT
ijpds-4052	18	11	has	have	AUX
ijpds-4052	18	12	currently	currently	ADV
ijpds-4052	18	13	approved	approve	VERB
ijpds-4052	18	14	10	10	NUM
ijpds-4052	18	15	medications	medication	NOUN
ijpds-4052	18	16	for	for	ADP
ijpds-4052	18	17	the	the	DET
ijpds-4052	18	18	treatment	treatment	NOUN
ijpds-4052	18	19	of	of	ADP
ijpds-4052	18	20	tb	tb	NOUN
ijpds-4052	18	21	.	.	PUNCT
ijpds-4052	18	22	isoniazid	isoniazid	PROPN
ijpds-4052	18	23	(	(	PUNCT
ijpds-4052	18	24	inh	inh	PROPN
ijpds-4052	18	25	)	)	PUNCT
ijpds-4052	18	26	,	,	PUNCT
ijpds-4052	18	27	rifampin	rifampin	PROPN
ijpds-4052	18	28	(	(	PUNCT
ijpds-4052	18	29	rif	rif	PROPN
ijpds-4052	18	30	)	)	PUNCT
ijpds-4052	18	31	,	,	PUNCT
ijpds-4052	18	32	ethambutol	ethambutol	X
ijpds-4052	18	33	(	(	PUNCT
ijpds-4052	18	34	emb	emb	NOUN
ijpds-4052	18	35	)	)	PUNCT
ijpds-4052	18	36	,	,	PUNCT
ijpds-4052	18	37	and	and	CCONJ
ijpds-4052	18	38	rifabutin	rifabutin	NOUN
ijpds-4052	18	39	are	be	AUX
ijpds-4052	18	40	recognized	recognize	VERB
ijpds-4052	18	41	medications	medication	NOUN
ijpds-4052	18	42	(	(	PUNCT
ijpds-4052	18	43	rb	rb	NOUN
ijpds-4052	18	44	)	)	PUNCT
ijpds-4052	19	1	[	[	X
ijpds-4052	19	2	3	3	NUM
ijpds-4052	19	3	]	]	PUNCT
ijpds-4052	19	4	.	.	PUNCT
ijpds-4052	20	1	who	who	PRON
ijpds-4052	20	2	estimates	estimate	VERB
ijpds-4052	20	3	that	that	SCONJ
ijpds-4052	20	4	tb	tb	NOUN
ijpds-4052	20	5	affects	affect	VERB
ijpds-4052	20	6	one	one	NUM
ijpds-4052	20	7	-	-	PUNCT
ijpds-4052	20	8	third	third	NOUN
ijpds-4052	20	9	of	of	ADP
ijpds-4052	20	10	the	the	DET
ijpds-4052	20	11	population	population	NOUN
ijpds-4052	20	12	and	and	CCONJ
ijpds-4052	20	13	dies	die	VERB
ijpds-4052	20	14	one	one	NUM
ijpds-4052	20	15	in	in	ADP
ijpds-4052	20	16	every	every	DET
ijpds-4052	20	17	four	four	NUM
ijpds-4052	20	18	adult	adult	NOUN
ijpds-4052	20	19	males	male	NOUN
ijpds-4052	20	20	.	.	PUNCT
ijpds-4052	21	1	primary	primary	ADJ
ijpds-4052	21	2	anti	anti	ADJ
ijpds-4052	21	3	-	-	ADJ
ijpds-4052	21	4	tb	tb	ADJ
ijpds-4052	21	5	medications	medication	NOUN
ijpds-4052	21	6	have	have	VERB
ijpds-4052	21	7	the	the	DET
ijpds-4052	21	8	potential	potential	NOUN
ijpds-4052	21	9	to	to	PART
ijpds-4052	21	10	be	be	AUX
ijpds-4052	21	11	hepatotoxic	hepatotoxic	ADJ
ijpds-4052	21	12	.	.	PUNCT
ijpds-4052	22	1	anti	anti	ADJ
ijpds-4052	22	2	-	-	ADJ
ijpds-4052	22	3	tb	tb	ADP
ijpds-4052	22	4	medications	medication	NOUN
ijpds-4052	22	5	inh	inh	PROPN
ijpds-4052	22	6	,	,	PUNCT
ijpds-4052	22	7	rif	rif	PROPN
ijpds-4052	22	8	,	,	PUNCT
ijpds-4052	22	9	and	and	CCONJ
ijpds-4052	22	10	rb	rb	PROPN
ijpds-4052	22	11	produce	produce	VERB
ijpds-4052	22	12	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	22	13	like	like	ADP
ijpds-4052	22	14	2	2	NUM
ijpds-4052	22	15	transaminases	transaminase	NOUN
ijpds-4052	22	16	and	and	CCONJ
ijpds-4052	22	17	severe	severe	ADJ
ijpds-4052	22	18	hepatitis	hepatitis	NOUN
ijpds-4052	22	19	failure	failure	NOUN
ijpds-4052	22	20	,	,	PUNCT
ijpds-4052	22	21	which	which	PRON
ijpds-4052	22	22	are	be	AUX
ijpds-4052	22	23	mentioned	mention	VERB
ijpds-4052	22	24	in	in	ADP
ijpds-4052	22	25	the	the	DET
ijpds-4052	22	26	first	first	ADJ
ijpds-4052	22	27	line	line	NOUN
ijpds-4052	22	28	.	.	PUNCT
ijpds-4052	23	1	depending	depend	VERB
ijpds-4052	23	2	on	on	ADP
ijpds-4052	23	3	the	the	DET
ijpds-4052	23	4	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	23	5	diagnosis	diagnosis	NOUN
ijpds-4052	23	6	criteria	criterion	NOUN
ijpds-4052	23	7	,	,	PUNCT
ijpds-4052	23	8	the	the	DET
ijpds-4052	23	9	anti	anti	ADJ
ijpds-4052	23	10	-	-	ADJ
ijpds-4052	23	11	tb	tb	ADJ
ijpds-4052	23	12	medication	medication	NOUN
ijpds-4052	23	13	can	can	AUX
ijpds-4052	23	14	cause	cause	VERB
ijpds-4052	23	15	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	23	16	in	in	ADP
ijpds-4052	23	17	3	3	NUM
ijpds-4052	23	18	to	to	PART
ijpds-4052	23	19	30	30	NUM
ijpds-4052	23	20	%	%	NOUN
ijpds-4052	23	21	of	of	ADP
ijpds-4052	23	22	cases	case	NOUN
ijpds-4052	23	23	[	[	X
ijpds-4052	23	24	4	4	NUM
ijpds-4052	23	25	]	]	PUNCT
ijpds-4052	23	26	.	.	PUNCT
ijpds-4052	24	1	seizures	seizure	NOUN
ijpds-4052	24	2	at	at	ADP
ijpds-4052	24	3	standard	standard	ADJ
ijpds-4052	24	4	doses	dose	NOUN
ijpds-4052	24	5	are	be	AUX
ijpds-4052	24	6	incredibly	incredibly	ADV
ijpds-4052	24	7	rare	rare	ADJ
ijpds-4052	24	8	to	to	PART
ijpds-4052	24	9	be	be	AUX
ijpds-4052	24	10	documented	document	VERB
ijpds-4052	24	11	.	.	PUNCT
ijpds-4052	25	1	this	this	DET
ijpds-4052	25	2	case	case	NOUN
ijpds-4052	25	3	study	study	NOUN
ijpds-4052	25	4	describes	describe	VERB
ijpds-4052	25	5	a	a	DET
ijpds-4052	25	6	convulsive	convulsive	ADJ
ijpds-4052	25	7	seizure	seizure	NOUN
ijpds-4052	25	8	that	that	PRON
ijpds-4052	25	9	happened	happen	VERB
ijpds-4052	25	10	after	after	ADP
ijpds-4052	25	11	receiving	receive	VERB
ijpds-4052	25	12	a	a	DET
ijpds-4052	25	13	short	short	ADJ
ijpds-4052	25	14	-	-	PUNCT
ijpds-4052	25	15	term	term	NOUN
ijpds-4052	25	16	therapeutic	therapeutic	ADJ
ijpds-4052	25	17	dose	dose	NOUN
ijpds-4052	25	18	of	of	ADP
ijpds-4052	25	19	inh	inh	PROPN
ijpds-4052	25	20	.	.	PUNCT
ijpds-4052	26	1	_	_	PUNCT
ijpds-4052	27	1	_	_	PUNCT
ijpds-4052	28	1	_	_	PUNCT
ijpds-4052	29	1	_	_	PUNCT
ijpds-4052	30	1	_	_	PUNCT
ijpds-4052	31	1	_	_	PUNCT
ijpds-4052	32	1	_	_	PUNCT
ijpds-4052	33	1	_	_	PUNCT
ijpds-4052	34	1	_	_	PUNCT
ijpds-4052	35	1	_	_	PUNCT
ijpds-4052	36	1	_	_	PUNCT
ijpds-4052	37	1	_	_	PUNCT
ijpds-4052	38	1	_	_	PUNCT
ijpds-4052	39	1	_	_	PUNCT
ijpds-4052	40	1	_	_	PUNCT
ijpds-4052	41	1	_	_	PUNCT
ijpds-4052	42	1	_	_	PUNCT
ijpds-4052	43	1	_	_	PUNCT
ijpds-4052	44	1	_	_	PUNCT
ijpds-4052	45	1	_	_	PUNCT
ijpds-4052	46	1	_	_	PUNCT
ijpds-4052	47	1	_	_	PUNCT
ijpds-4052	48	1	_	_	PUNCT
ijpds-4052	49	1	_	_	PUNCT
ijpds-4052	50	1	_	_	PUNCT
ijpds-4052	51	1	_	_	PUNCT
ijpds-4052	52	1	_	_	PUNCT
ijpds-4052	53	1	_	_	PUNCT
ijpds-4052	54	1	_	_	PUNCT
ijpds-4052	55	1	_	_	PUNCT
ijpds-4052	56	1	_	_	PUNCT
ijpds-4052	57	1	_	_	PUNCT
ijpds-4052	58	1	_	_	PUNCT
ijpds-4052	59	1	_	_	PUNCT
ijpds-4052	60	1	_	_	PUNCT
ijpds-4052	61	1	_	_	PUNCT
ijpds-4052	62	1	_	_	PUNCT
ijpds-4052	63	1	_	_	PUNCT
ijpds-4052	64	1	_	_	PUNCT
ijpds-4052	64	2	correspondence	correspondence	NOUN
ijpds-4052	64	3	to	to	ADP
ijpds-4052	64	4	:	:	PUNCT
ijpds-4052	64	5	utpal	utpal	PROPN
ijpds-4052	64	6	bhui	bhui	PROPN
ijpds-4052	64	7	,	,	PUNCT
ijpds-4052	64	8	jhanjhra	jhanjhra	PROPN
ijpds-4052	64	9	colony	colony	NOUN
ijpds-4052	64	10	,	,	PUNCT
ijpds-4052	64	11	b	b	PRON
ijpds-4052	64	12	type	type	NOUN
ijpds-4052	64	13	30/178	30/178	NUM
ijpds-4052	64	14	,	,	PUNCT
ijpds-4052	64	15	paschim	paschim	NOUN
ijpds-4052	64	16	bardhaman	bardhaman	NOUN
ijpds-4052	64	17	,	,	PUNCT
ijpds-4052	64	18	west	west	PROPN
ijpds-4052	64	19	bengal713385	bengal713385	PROPN
ijpds-4052	64	20	email	email	NOUN
ijpds-4052	64	21	:	:	PUNCT
ijpds-4052	64	22	bhuiutpal875@gmail.com	bhuiutpal875@gmail.com	X
ijpds-4052	64	23	,	,	PUNCT
ijpds-4052	64	24	tel	tel	ADP
ijpds-4052	64	25	:	:	PUNCT
ijpds-4052	64	26	+91	+91	NOUN
ijpds-4052	64	27	7001719578	7001719578	NUM
ijpds-4052	64	28	m	m	VERB
ijpds-4052	64	29	mailto:bhuiutpal875@gmail.com	mailto:bhuiutpal875@gmail.com	PROPN
ijpds-4052	64	30	bhui	bhui	NOUN
ijpds-4052	64	31	u	u	PROPN
ijpds-4052	64	32	et	et	PROPN
ijpds-4052	64	33	al	al	PROPN
ijpds-4052	64	34	.	.	PUNCT
ijpds-4052	64	35	anti	anti	ADJ
ijpds-4052	64	36	-	-	ADJ
ijpds-4052	64	37	tubercular	tubercular	ADJ
ijpds-4052	64	38	drug	drug	NOUN
ijpds-4052	64	39	-	-	PUNCT
ijpds-4052	64	40	induced	induce	VERB
ijpds-4052	64	41	vitamin	vitamin	NOUN
ijpds-4052	64	42	b6	b6	NOUN
ijpds-4052	64	43	deficiency	deficiency	NOUN
ijpds-4052	64	44	vol	vol	NOUN
ijpds-4052	64	45	2	2	NUM
ijpds-4052	64	46	|	|	NOUN
ijpds-4052	64	47	issue	issue	VERB
ijpds-4052	64	48	3	3	NUM
ijpds-4052	64	49	|	|	ADV
ijpds-4052	64	50	jul	jul	PROPN
ijpds-4052	64	51	–	–	PUNCT
ijpds-4052	64	52	sep	sep	PROPN
ijpds-4052	64	53	2023	2023	NUM
ijpds-4052	64	54	indian	indian	PROPN
ijpds-4052	64	55	j	j	PROPN
ijpds-4052	64	56	pharm	pharm	PROPN
ijpds-4052	64	57	drug	drug	PROPN
ijpds-4052	64	58	studies	study	NOUN
ijpds-4052	64	59	|	|	ADV
ijpds-4052	64	60	125	125	NUM
ijpds-4052	64	61	case	case	NOUN
ijpds-4052	64	62	report	report	NOUN
ijpds-4052	64	63	despite	despite	SCONJ
ijpds-4052	64	64	having	have	VERB
ijpds-4052	64	65	a	a	DET
ijpds-4052	64	66	known	known	ADJ
ijpds-4052	64	67	case	case	NOUN
ijpds-4052	64	68	of	of	ADP
ijpds-4052	64	69	pulmonary	pulmonary	ADJ
ijpds-4052	64	70	tuberculosis	tuberculosis	NOUN
ijpds-4052	64	71	and	and	CCONJ
ijpds-4052	64	72	being	be	AUX
ijpds-4052	64	73	on	on	ADP
ijpds-4052	64	74	cat	cat	NOUN
ijpds-4052	64	75	1	1	NUM
ijpds-4052	64	76	atd	atd	PROPN
ijpds-4052	64	77	,	,	PUNCT
ijpds-4052	64	78	a	a	DET
ijpds-4052	64	79	65	65	NUM
ijpds-4052	64	80	-	-	PUNCT
ijpds-4052	64	81	year	year	NOUN
ijpds-4052	64	82	-	-	PUNCT
ijpds-4052	64	83	old	old	ADJ
ijpds-4052	64	84	female	female	ADJ
ijpds-4052	64	85	patient	patient	NOUN
ijpds-4052	64	86	recently	recently	ADV
ijpds-4052	64	87	presented	present	VERB
ijpds-4052	64	88	with	with	ADP
ijpds-4052	64	89	the	the	DET
ijpds-4052	64	90	cause	cause	NOUN
ijpds-4052	64	91	of	of	ADP
ijpds-4052	64	92	appetite	appetite	NOUN
ijpds-4052	64	93	,	,	PUNCT
ijpds-4052	64	94	decreased	decrease	VERB
ijpds-4052	64	95	food	food	NOUN
ijpds-4052	64	96	intake	intake	NOUN
ijpds-4052	64	97	,	,	PUNCT
ijpds-4052	64	98	nausea	nausea	NOUN
ijpds-4052	64	99	/	/	SYM
ijpds-4052	64	100	vomiting	vomiting	NOUN
ijpds-4052	64	101	,	,	PUNCT
ijpds-4052	64	102	and	and	CCONJ
ijpds-4052	64	103	extreme	extreme	ADJ
ijpds-4052	64	104	fatigability	fatigability	NOUN
ijpds-4052	64	105	.	.	PUNCT
ijpds-4052	65	1	she	she	PRON
ijpds-4052	65	2	is	be	AUX
ijpds-4052	65	3	a	a	DET
ijpds-4052	65	4	known	known	ADJ
ijpds-4052	65	5	case	case	NOUN
ijpds-4052	65	6	of	of	ADP
ijpds-4052	65	7	tb	tb	NOUN
ijpds-4052	65	8	from	from	ADP
ijpds-4052	65	9	eight	eight	NUM
ijpds-4052	65	10	months	month	NOUN
ijpds-4052	65	11	ago	ago	ADV
ijpds-4052	65	12	in	in	ADP
ijpds-4052	65	13	the	the	DET
ijpds-4052	65	14	patient	patient	NOUN
ijpds-4052	65	15	's	's	PART
ijpds-4052	65	16	previous	previous	ADJ
ijpds-4052	65	17	medical	medical	ADJ
ijpds-4052	65	18	history	history	NOUN
ijpds-4052	65	19	.	.	PUNCT
ijpds-4052	66	1	an	an	DET
ijpds-4052	66	2	old	old	ADJ
ijpds-4052	66	3	high	high	ADJ
ijpds-4052	66	4	resolution	resolution	NOUN
ijpds-4052	66	5	ct	ct	PROPN
ijpds-4052	66	6	scan	scan	PROPN
ijpds-4052	66	7	thorax	thorax	PROPN
ijpds-4052	66	8	showed	show	VERB
ijpds-4052	66	9	irregular	irregular	ADJ
ijpds-4052	66	10	cavities	cavity	NOUN
ijpds-4052	66	11	in	in	ADP
ijpds-4052	66	12	the	the	DET
ijpds-4052	66	13	right	right	ADJ
ijpds-4052	66	14	upper	upper	ADJ
ijpds-4052	66	15	and	and	CCONJ
ijpds-4052	66	16	lower	low	ADJ
ijpds-4052	66	17	lobes	lobe	NOUN
ijpds-4052	66	18	,	,	PUNCT
ijpds-4052	66	19	centrilobular	centrilobular	ADJ
ijpds-4052	66	20	nodules	nodule	NOUN
ijpds-4052	66	21	in	in	ADP
ijpds-4052	66	22	both	both	DET
ijpds-4052	66	23	lungs	lung	NOUN
ijpds-4052	66	24	collapsing	collapse	VERB
ijpds-4052	66	25	with	with	ADP
ijpds-4052	66	26	bronchiectasis	bronchiectasis	NOUN
ijpds-4052	66	27	in	in	ADP
ijpds-4052	66	28	the	the	DET
ijpds-4052	66	29	right	right	ADJ
ijpds-4052	66	30	middle	middle	ADJ
ijpds-4052	66	31	lobe	lobe	PROPN
ijpds-4052	66	32	,	,	PUNCT
ijpds-4052	66	33	and	and	CCONJ
ijpds-4052	66	34	a	a	DET
ijpds-4052	66	35	tiny	tiny	ADJ
ijpds-4052	66	36	(	(	PUNCT
ijpds-4052	66	37	r	r	NOUN
ijpds-4052	66	38	)	)	PUNCT
ijpds-4052	66	39	para	para	NOUN
ijpds-4052	66	40	tracheal	tracheal	NOUN
ijpds-4052	66	41	pulmonary	pulmonary	PROPN
ijpds-4052	66	42	koch	koch	PROPN
ijpds-4052	66	43	's	's	PART
ijpds-4052	66	44	infection	infection	NOUN
ijpds-4052	66	45	found	find	VERB
ijpds-4052	66	46	on	on	ADP
ijpds-4052	66	47	the	the	DET
ijpds-4052	66	48	chest	chest	NOUN
ijpds-4052	66	49	.	.	PUNCT
ijpds-4052	67	1	the	the	DET
ijpds-4052	67	2	ecg	ecg	PROPN
ijpds-4052	67	3	report	report	NOUN
ijpds-4052	67	4	overloaded	overload	VERB
ijpds-4052	67	5	the	the	DET
ijpds-4052	67	6	left	left	ADJ
ijpds-4052	67	7	atrium	atrium	NOUN
ijpds-4052	67	8	excessively	excessively	ADV
ijpds-4052	67	9	,	,	PUNCT
ijpds-4052	67	10	and	and	CCONJ
ijpds-4052	67	11	an	an	DET
ijpds-4052	67	12	ultrasound	ultrasound	NOUN
ijpds-4052	67	13	scan	scan	NOUN
ijpds-4052	67	14	reveals	reveal	VERB
ijpds-4052	67	15	a	a	DET
ijpds-4052	67	16	bladder	bladder	NOUN
ijpds-4052	67	17	outflow	outflow	NOUN
ijpds-4052	67	18	obstruction	obstruction	NOUN
ijpds-4052	67	19	.	.	PUNCT
ijpds-4052	68	1	table	table	NOUN
ijpds-4052	68	2	1	1	NUM
ijpds-4052	68	3	laboratory	laboratory	NOUN
ijpds-4052	68	4	investigation	investigation	NOUN
ijpds-4052	68	5	on	on	ADP
ijpds-4052	68	6	admission	admission	NOUN
ijpds-4052	68	7	,	,	PUNCT
ijpds-4052	68	8	the	the	DET
ijpds-4052	68	9	patient	patient	NOUN
ijpds-4052	68	10	was	be	AUX
ijpds-4052	68	11	started	start	VERB
ijpds-4052	68	12	on	on	ADP
ijpds-4052	68	13	antibiotics	antibiotic	NOUN
ijpds-4052	68	14	,	,	PUNCT
ijpds-4052	68	15	hepatoprotective	hepatoprotective	ADJ
ijpds-4052	68	16	medications	medication	NOUN
ijpds-4052	68	17	,	,	PUNCT
ijpds-4052	68	18	laxatives	laxative	NOUN
ijpds-4052	68	19	,	,	PUNCT
ijpds-4052	68	20	and	and	CCONJ
ijpds-4052	68	21	a	a	DET
ijpds-4052	68	22	single	single	ADJ
ijpds-4052	68	23	antitubercular	antitubercular	ADJ
ijpds-4052	68	24	drug	drug	NOUN
ijpds-4052	68	25	were	be	AUX
ijpds-4052	68	26	used	use	VERB
ijpds-4052	68	27	as	as	ADP
ijpds-4052	68	28	part	part	NOUN
ijpds-4052	68	29	of	of	ADP
ijpds-4052	68	30	this	this	DET
ijpds-4052	68	31	therapeutic	therapeutic	ADJ
ijpds-4052	68	32	regimen	regiman	NOUN
ijpds-4052	68	33	to	to	PART
ijpds-4052	68	34	treat	treat	VERB
ijpds-4052	68	35	the	the	DET
ijpds-4052	68	36	main	main	ADJ
ijpds-4052	68	37	symptoms	symptom	NOUN
ijpds-4052	68	38	of	of	ADP
ijpds-4052	68	39	appetite	appetite	ADJ
ijpds-4052	68	40	loss	loss	NOUN
ijpds-4052	68	41	,	,	PUNCT
ijpds-4052	68	42	nausea	nausea	NOUN
ijpds-4052	68	43	,	,	PUNCT
ijpds-4052	68	44	and	and	CCONJ
ijpds-4052	68	45	exhaustion	exhaustion	NOUN
ijpds-4052	68	46	.	.	PUNCT
ijpds-4052	69	1	decreasing	decrease	VERB
ijpds-4052	69	2	the	the	DET
ijpds-4052	69	3	levels	level	NOUN
ijpds-4052	69	4	of	of	ADP
ijpds-4052	69	5	sgot	sgot	NOUN
ijpds-4052	69	6	/	/	SYM
ijpds-4052	69	7	ast	ast	PROPN
ijpds-4052	69	8	,	,	PUNCT
ijpds-4052	69	9	sgpt	sgpt	NOUN
ijpds-4052	69	10	/	/	SYM
ijpds-4052	69	11	alt	alt	ADJ
ijpds-4052	69	12	,	,	PUNCT
ijpds-4052	69	13	direct	direct	ADJ
ijpds-4052	69	14	and	and	CCONJ
ijpds-4052	69	15	indirect	indirect	ADJ
ijpds-4052	69	16	bilirubin	bilirubin	NOUN
ijpds-4052	69	17	,	,	PUNCT
ijpds-4052	69	18	and	and	CCONJ
ijpds-4052	69	19	bilirubin	bilirubin	NOUN
ijpds-4052	69	20	.	.	PUNCT
ijpds-4052	70	1	antibiotics	antibiotic	NOUN
ijpds-4052	70	2	,	,	PUNCT
ijpds-4052	70	3	anti	anti	ADJ
ijpds-4052	70	4	-	-	ADJ
ijpds-4052	70	5	tubercular	tubercular	ADJ
ijpds-4052	70	6	agents	agent	NOUN
ijpds-4052	70	7	,	,	PUNCT
ijpds-4052	70	8	and	and	CCONJ
ijpds-4052	70	9	hepatoprotective	hepatoprotective	ADJ
ijpds-4052	70	10	agents	agent	NOUN
ijpds-4052	70	11	for	for	ADP
ijpds-4052	70	12	the	the	DET
ijpds-4052	70	13	treatment	treatment	NOUN
ijpds-4052	70	14	of	of	ADP
ijpds-4052	70	15	severe	severe	ADJ
ijpds-4052	70	16	tuberculosis	tuberculosis	NOUN
ijpds-4052	70	17	in	in	ADP
ijpds-4052	70	18	the	the	DET
ijpds-4052	70	19	patient	patient	NOUN
ijpds-4052	70	20	and	and	CCONJ
ijpds-4052	70	21	reducing	reduce	VERB
ijpds-4052	70	22	the	the	DET
ijpds-4052	70	23	bilirubin	bilirubin	NOUN
ijpds-4052	70	24	range	range	NOUN
ijpds-4052	70	25	but	but	CCONJ
ijpds-4052	70	26	the	the	DET
ijpds-4052	70	27	patient	patient	NOUN
ijpds-4052	70	28	developed	develop	VERB
ijpds-4052	70	29	a	a	DET
ijpds-4052	70	30	disturbance	disturbance	NOUN
ijpds-4052	70	31	of	of	ADP
ijpds-4052	70	32	consciousness	consciousness	NOUN
ijpds-4052	70	33	and	and	CCONJ
ijpds-4052	70	34	tonic	tonic	NOUN
ijpds-4052	70	35	-	-	PUNCT
ijpds-4052	70	36	clonic	clonic	NOUN
ijpds-4052	70	37	convulsions	convulsion	NOUN
ijpds-4052	70	38	(	(	PUNCT
ijpds-4052	70	39	figure	figure	NOUN
ijpds-4052	70	40	1	1	NUM
ijpds-4052	70	41	)	)	PUNCT
ijpds-4052	70	42	.	.	PUNCT
ijpds-4052	71	1	on	on	ADP
ijpds-4052	71	2	examination	examination	NOUN
ijpds-4052	71	3	,	,	PUNCT
ijpds-4052	71	4	her	her	PRON
ijpds-4052	71	5	blood	blood	NOUN
ijpds-4052	71	6	pressure	pressure	NOUN
ijpds-4052	71	7	was	be	AUX
ijpds-4052	71	8	180/92	180/92	NUM
ijpds-4052	71	9	mmhg	mmhg	NOUN
ijpds-4052	71	10	,	,	PUNCT
ijpds-4052	71	11	her	her	PRON
ijpds-4052	71	12	temperature	temperature	NOUN
ijpds-4052	71	13	was	be	AUX
ijpds-4052	71	14	36.3ºc	36.3ºc	NOUN
ijpds-4052	71	15	,	,	PUNCT
ijpds-4052	71	16	her	her	PRON
ijpds-4052	71	17	heart	heart	NOUN
ijpds-4052	71	18	rate	rate	NOUN
ijpds-4052	71	19	was	be	AUX
ijpds-4052	71	20	107	107	NUM
ijpds-4052	71	21	beats	beat	NOUN
ijpds-4052	71	22	/	/	SYM
ijpds-4052	71	23	min	min	NOUN
ijpds-4052	71	24	,	,	PUNCT
ijpds-4052	71	25	her	her	PRON
ijpds-4052	71	26	respiratory	respiratory	ADJ
ijpds-4052	71	27	rate	rate	NOUN
ijpds-4052	71	28	was	be	AUX
ijpds-4052	71	29	26	26	NUM
ijpds-4052	71	30	breaths	breath	NOUN
ijpds-4052	71	31	/	/	SYM
ijpds-4052	71	32	min	min	NOUN
ijpds-4052	71	33	,	,	PUNCT
ijpds-4052	71	34	and	and	CCONJ
ijpds-4052	71	35	her	her	PRON
ijpds-4052	71	36	oxygen	oxygen	NOUN
ijpds-4052	71	37	saturation	saturation	NOUN
ijpds-4052	71	38	was	be	AUX
ijpds-4052	71	39	97	97	NUM
ijpds-4052	71	40	%	%	NOUN
ijpds-4052	71	41	on	on	ADP
ijpds-4052	71	42	room	room	NOUN
ijpds-4052	71	43	air	air	NOUN
ijpds-4052	71	44	.	.	PUNCT
ijpds-4052	72	1	the	the	DET
ijpds-4052	72	2	findings	finding	NOUN
ijpds-4052	72	3	of	of	ADP
ijpds-4052	72	4	the	the	DET
ijpds-4052	72	5	systemic	systemic	ADJ
ijpds-4052	72	6	examination	examination	NOUN
ijpds-4052	72	7	was	be	AUX
ijpds-4052	72	8	normal	normal	ADJ
ijpds-4052	72	9	.	.	PUNCT
ijpds-4052	73	1	no	no	DET
ijpds-4052	73	2	abnormal	abnormal	ADJ
ijpds-4052	73	3	findings	finding	NOUN
ijpds-4052	73	4	were	be	AUX
ijpds-4052	73	5	detected	detect	VERB
ijpds-4052	73	6	on	on	ADP
ijpds-4052	73	7	head	head	NOUN
ijpds-4052	73	8	ct	ct	PROPN
ijpds-4052	73	9	scans	scan	NOUN
ijpds-4052	73	10	.	.	PUNCT
ijpds-4052	74	1	the	the	DET
ijpds-4052	74	2	user	user	NOUN
ijpds-4052	74	3	laboratory	laboratory	NOUN
ijpds-4052	74	4	finding	finding	NOUN
ijpds-4052	74	5	for	for	ADP
ijpds-4052	74	6	causes	cause	NOUN
ijpds-4052	74	7	of	of	ADP
ijpds-4052	74	8	convulsion	convulsion	NOUN
ijpds-4052	74	9	was	be	AUX
ijpds-4052	74	10	absent	absent	ADJ
ijpds-4052	74	11	,	,	PUNCT
ijpds-4052	74	12	except	except	SCONJ
ijpds-4052	74	13	for	for	ADP
ijpds-4052	74	14	the	the	DET
ijpds-4052	74	15	important	important	ADJ
ijpds-4052	74	16	finding	finding	NOUN
ijpds-4052	74	17	of	of	ADP
ijpds-4052	74	18	the	the	DET
ijpds-4052	74	19	patient	patient	NOUN
ijpds-4052	74	20	's	's	PART
ijpds-4052	74	21	serum	serum	NOUN
ijpds-4052	74	22	,	,	PUNCT
ijpds-4052	74	23	vitamin	vitamin	NOUN
ijpds-4052	74	24	b6	b6	NOUN
ijpds-4052	74	25	level	level	NOUN
ijpds-4052	74	26	was	be	AUX
ijpds-4052	74	27	low	low	ADJ
ijpds-4052	74	28	(	(	PUNCT
ijpds-4052	74	29	table	table	NOUN
ijpds-4052	74	30	1	1	NUM
ijpds-4052	74	31	)	)	PUNCT
ijpds-4052	74	32	.	.	PUNCT
ijpds-4052	75	1	this	this	PRON
ijpds-4052	75	2	leads	lead	VERB
ijpds-4052	75	3	us	we	PRON
ijpds-4052	75	4	to	to	PART
ijpds-4052	75	5	diagnose	diagnose	VERB
ijpds-4052	75	6	the	the	DET
ijpds-4052	75	7	patient	patient	NOUN
ijpds-4052	75	8	with	with	ADP
ijpds-4052	75	9	convulsive	convulsive	ADJ
ijpds-4052	75	10	seizure	seizure	NOUN
ijpds-4052	75	11	due	due	ADP
ijpds-4052	75	12	to	to	ADP
ijpds-4052	75	13	vitamin	vitamin	NOUN
ijpds-4052	75	14	b6	b6	NOUN
ijpds-4052	75	15	deficiency	deficiency	NOUN
ijpds-4052	75	16	is	be	AUX
ijpds-4052	75	17	associated	associate	VERB
ijpds-4052	75	18	with	with	ADP
ijpds-4052	75	19	isoniazid	isoniazid	NOUN
ijpds-4052	75	20	which	which	PRON
ijpds-4052	75	21	is	be	AUX
ijpds-4052	75	22	involved	involve	VERB
ijpds-4052	75	23	in	in	ADP
ijpds-4052	75	24	the	the	DET
ijpds-4052	75	25	cat	cat	NOUN
ijpds-4052	75	26	1	1	NUM
ijpds-4052	75	27	atd	atd	PROPN
ijpds-4052	75	28	.	.	PUNCT
ijpds-4052	76	1	the	the	DET
ijpds-4052	76	2	justification	justification	NOUN
ijpds-4052	76	3	for	for	ADP
ijpds-4052	76	4	therapystops	therapystop	NOUN
ijpds-4052	76	5	cat	cat	NOUN
ijpds-4052	76	6	1	1	NUM
ijpds-4052	76	7	atd	atd	PROPN
ijpds-4052	76	8	,	,	PUNCT
ijpds-4052	76	9	causing	cause	VERB
ijpds-4052	76	10	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	76	11	and	and	CCONJ
ijpds-4052	76	12	convulsive	convulsive	ADJ
ijpds-4052	76	13	seizure	seizure	NOUN
ijpds-4052	76	14	to	to	ADP
ijpds-4052	76	15	the	the	DET
ijpds-4052	76	16	patient	patient	NOUN
ijpds-4052	76	17	.	.	PUNCT
ijpds-4052	77	1	during	during	ADP
ijpds-4052	77	2	follow	follow	NOUN
ijpds-4052	77	3	-	-	PUNCT
ijpds-4052	77	4	up	up	NOUN
ijpds-4052	77	5	,	,	PUNCT
ijpds-4052	77	6	no	no	DET
ijpds-4052	77	7	medication	medication	NOUN
ijpds-4052	77	8	interactions	interaction	NOUN
ijpds-4052	77	9	are	be	AUX
ijpds-4052	77	10	discovered	discover	VERB
ijpds-4052	77	11	after	after	ADP
ijpds-4052	77	12	rational	rational	ADJ
ijpds-4052	77	13	drug	drug	NOUN
ijpds-4052	77	14	administration	administration	NOUN
ijpds-4052	77	15	.	.	PUNCT
ijpds-4052	78	1	figure	figure	NOUN
ijpds-4052	78	2	1	1	NUM
ijpds-4052	78	3	:	:	PUNCT
ijpds-4052	78	4	clinical	clinical	ADJ
ijpds-4052	78	5	course	course	NOUN
ijpds-4052	78	6	of	of	ADP
ijpds-4052	78	7	the	the	DET
ijpds-4052	78	8	patient	patient	NOUN
ijpds-4052	78	9	.	.	PUNCT
ijpds-4052	79	1	convulsive	convulsive	ADJ
ijpds-4052	79	2	seizure	seizure	NOUN
ijpds-4052	79	3	occurred	occur	VERB
ijpds-4052	79	4	eleven	eleven	NUM
ijpds-4052	79	5	days	day	NOUN
ijpds-4052	79	6	after	after	ADP
ijpds-4052	79	7	the	the	DET
ijpds-4052	79	8	administration	administration	NOUN
ijpds-4052	79	9	of	of	ADP
ijpds-4052	79	10	antitubercular	antitubercular	ADJ
ijpds-4052	79	11	drugs	drug	NOUN
ijpds-4052	79	12	.	.	PUNCT
ijpds-4052	80	1	seizure	seizure	VERB
ijpds-4052	80	2	refractory	refractory	NOUN
ijpds-4052	80	3	to	to	ADP
ijpds-4052	80	4	standard	standard	ADJ
ijpds-4052	80	5	anticonvulsant	anticonvulsant	ADJ
ijpds-4052	80	6	therapy	therapy	NOUN
ijpds-4052	80	7	were	be	AUX
ijpds-4052	80	8	controlled	control	VERB
ijpds-4052	80	9	with	with	ADP
ijpds-4052	80	10	the	the	DET
ijpds-4052	80	11	administration	administration	NOUN
ijpds-4052	80	12	of	of	ADP
ijpds-4052	80	13	pyridoxal	pyridoxal	ADJ
ijpds-4052	80	14	phosphate	phosphate	ADJ
ijpds-4052	80	15	hydrate	hydrate	NOUN
ijpds-4052	80	16	(	(	PUNCT
ijpds-4052	80	17	vitamin	vitamin	NOUN
ijpds-4052	80	18	b-6	b-6	NOUN
ijpds-4052	80	19	)	)	PUNCT
ijpds-4052	80	20	.	.	PUNCT
ijpds-4052	81	1	emb	emb	PROPN
ijpds-4052	81	2	:	:	PUNCT
ijpds-4052	81	3	ethambutol	ethambutol	ADV
ijpds-4052	81	4	,	,	PUNCT
ijpds-4052	81	5	rif	rif	ADJ
ijpds-4052	81	6	:	:	PUNCT
ijpds-4052	81	7	rifampin	rifampin	NOUN
ijpds-4052	81	8	,	,	PUNCT
ijpds-4052	81	9	inh	inh	PROPN
ijpds-4052	81	10	:	:	PUNCT
ijpds-4052	81	11	isoniazid	isoniazid	PROPN
ijpds-4052	81	12	,	,	PUNCT
ijpds-4052	81	13	pht	pht	PROPN
ijpds-4052	81	14	:	:	PUNCT
ijpds-4052	81	15	phenytoin	phenytoin	PROPN
ijpds-4052	81	16	.	.	PUNCT
ijpds-4052	82	1	discussion	discussion	NOUN
ijpds-4052	82	2	in	in	ADP
ijpds-4052	82	3	india	india	PROPN
ijpds-4052	82	4	,	,	PUNCT
ijpds-4052	82	5	8	8	NUM
ijpds-4052	82	6	-	-	SYM
ijpds-4052	82	7	36	36	NUM
ijpds-4052	82	8	%	%	NOUN
ijpds-4052	82	9	of	of	ADP
ijpds-4052	82	10	cases	case	NOUN
ijpds-4052	82	11	of	of	ADP
ijpds-4052	82	12	drug	drug	NOUN
ijpds-4052	82	13	-	-	PUNCT
ijpds-4052	82	14	induced	induce	VERB
ijpds-4052	82	15	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	82	16	occur	occur	VERB
ijpds-4052	82	17	.	.	PUNCT
ijpds-4052	83	1	asian	asian	ADJ
ijpds-4052	83	2	nations	nation	NOUN
ijpds-4052	83	3	have	have	VERB
ijpds-4052	83	4	a	a	DET
ijpds-4052	83	5	greater	great	ADJ
ijpds-4052	83	6	rate	rate	NOUN
ijpds-4052	83	7	of	of	ADP
ijpds-4052	83	8	drug	drug	NOUN
ijpds-4052	83	9	-	-	PUNCT
ijpds-4052	83	10	induced	induce	VERB
ijpds-4052	83	11	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	83	12	(	(	PUNCT
ijpds-4052	83	13	dih	dih	PROPN
ijpds-4052	83	14	)	)	PUNCT
ijpds-4052	83	15	,	,	PUNCT
ijpds-4052	83	16	which	which	PRON
ijpds-4052	83	17	may	may	AUX
ijpds-4052	83	18	be	be	AUX
ijpds-4052	83	19	attributed	attribute	VERB
ijpds-4052	83	20	to	to	ADP
ijpds-4052	83	21	racial	racial	ADJ
ijpds-4052	83	22	vulnerability	vulnerability	NOUN
ijpds-4052	83	23	,	,	PUNCT
ijpds-4052	83	24	the	the	DET
ijpds-4052	83	25	peculiarities	peculiarity	NOUN
ijpds-4052	83	26	of	of	ADP
ijpds-4052	83	27	drug	drug	NOUN
ijpds-4052	83	28	metabolism	metabolism	NOUN
ijpds-4052	83	29	,	,	PUNCT
ijpds-4052	83	30	and	and	CCONJ
ijpds-4052	83	31	the	the	DET
ijpds-4052	83	32	existence	existence	NOUN
ijpds-4052	83	33	of	of	ADP
ijpds-4052	83	34	numerous	numerous	ADJ
ijpds-4052	83	35	known	know	VERB
ijpds-4052	83	36	risk	risk	NOUN
ijpds-4052	83	37	factors	factor	NOUN
ijpds-4052	83	38	such	such	ADJ
ijpds-4052	83	39	hiv	hiv	PROPN
ijpds-4052	83	40	infections	infection	NOUN
ijpds-4052	83	41	,	,	PUNCT
ijpds-4052	83	42	nutritional	nutritional	ADJ
ijpds-4052	83	43	deficiencies	deficiency	NOUN
ijpds-4052	83	44	,	,	PUNCT
ijpds-4052	83	45	and	and	CCONJ
ijpds-4052	83	46	alcoholism	alcoholism	NOUN
ijpds-4052	83	47	[	[	X
ijpds-4052	83	48	5	5	NUM
ijpds-4052	83	49	]	]	PUNCT
ijpds-4052	83	50	.	.	PUNCT
ijpds-4052	84	1	the	the	DET
ijpds-4052	84	2	causes	cause	NOUN
ijpds-4052	84	3	of	of	ADP
ijpds-4052	84	4	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	84	5	in	in	ADP
ijpds-4052	84	6	patients	patient	NOUN
ijpds-4052	84	7	range	range	VERB
ijpds-4052	84	8	between	between	ADP
ijpds-4052	84	9	1	1	NUM
ijpds-4052	84	10	and	and	CCONJ
ijpds-4052	84	11	10	10	NUM
ijpds-4052	84	12	%	%	NOUN
ijpds-4052	84	13	across	across	ADP
ijpds-4052	84	14	different	different	ADJ
ijpds-4052	84	15	nations	nation	NOUN
ijpds-4052	84	16	,	,	PUNCT
ijpds-4052	84	17	depending	depend	VERB
ijpds-4052	84	18	on	on	ADP
ijpds-4052	84	19	elements	element	NOUN
ijpds-4052	84	20	like	like	ADP
ijpds-4052	84	21	social	social	ADJ
ijpds-4052	84	22	and	and	CCONJ
ijpds-4052	84	23	economic	economic	ADJ
ijpds-4052	84	24	situations	situation	NOUN
ijpds-4052	84	25	as	as	ADV
ijpds-4052	84	26	well	well	ADV
ijpds-4052	84	27	as	as	ADP
ijpds-4052	84	28	geographic	geographic	ADJ
ijpds-4052	84	29	location	location	NOUN
ijpds-4052	84	30	.	.	PUNCT
ijpds-4052	85	1	india	india	PROPN
ijpds-4052	85	2	(	(	PUNCT
ijpds-4052	85	3	8–10	8–10	NOUN
ijpds-4052	85	4	%	%	NOUN
ijpds-4052	85	5	)	)	PUNCT
ijpds-4052	85	6	has	have	VERB
ijpds-4052	85	7	the	the	DET
ijpds-4052	85	8	highest	high	ADJ
ijpds-4052	85	9	rate	rate	NOUN
ijpds-4052	85	10	of	of	ADP
ijpds-4052	85	11	druginduced	druginduced	ADJ
ijpds-4052	85	12	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	85	13	,	,	PUNCT
ijpds-4052	85	14	which	which	PRON
ijpds-4052	85	15	may	may	AUX
ijpds-4052	85	16	be	be	AUX
ijpds-4052	85	17	related	relate	VERB
ijpds-4052	85	18	to	to	ADP
ijpds-4052	85	19	genetics	genetic	NOUN
ijpds-4052	85	20	,	,	PUNCT
ijpds-4052	85	21	chronic	chronic	ADJ
ijpds-4052	85	22	viral	viral	ADJ
ijpds-4052	85	23	hepatitis	hepatitis	NOUN
ijpds-4052	85	24	,	,	PUNCT
ijpds-4052	85	25	malnutrition	malnutrition	NOUN
ijpds-4052	85	26	,	,	PUNCT
ijpds-4052	85	27	and	and	CCONJ
ijpds-4052	85	28	drunkenness	drunkenness	NOUN
ijpds-4052	86	1	[	[	X
ijpds-4052	86	2	6	6	NUM
ijpds-4052	86	3	]	]	PUNCT
ijpds-4052	86	4	.	.	PUNCT
ijpds-4052	87	1	in	in	ADP
ijpds-4052	87	2	the	the	DET
ijpds-4052	87	3	intrinsic	intrinsic	ADJ
ijpds-4052	87	4	phase	phase	NOUN
ijpds-4052	87	5	of	of	ADP
ijpds-4052	87	6	treatment	treatment	NOUN
ijpds-4052	87	7	,	,	PUNCT
ijpds-4052	87	8	which	which	PRON
ijpds-4052	87	9	is	be	AUX
ijpds-4052	87	10	determined	determine	VERB
ijpds-4052	87	11	by	by	ADP
ijpds-4052	87	12	the	the	DET
ijpds-4052	87	13	etiology	etiology	NOUN
ijpds-4052	87	14	of	of	ADP
ijpds-4052	87	15	the	the	DET
ijpds-4052	87	16	second	second	ADJ
ijpds-4052	87	17	-	-	PUNCT
ijpds-4052	87	18	line	line	NOUN
ijpds-4052	87	19	injectable	injectable	ADJ
ijpds-4052	87	20	agent	agent	NOUN
ijpds-4052	87	21	,	,	PUNCT
ijpds-4052	87	22	the	the	PRON
ijpds-4052	87	23	who	who	PRON
ijpds-4052	87	24	has	have	AUX
ijpds-4052	87	25	recommended	recommend	VERB
ijpds-4052	87	26	at	at	ADP
ijpds-4052	87	27	least	least	ADV
ijpds-4052	87	28	five	five	NUM
ijpds-4052	87	29	medications	medication	NOUN
ijpds-4052	87	30	[	[	X
ijpds-4052	87	31	7	7	NUM
ijpds-4052	87	32	]	]	PUNCT
ijpds-4052	87	33	.	.	PUNCT
ijpds-4052	88	1	it	it	PRON
ijpds-4052	88	2	is	be	AUX
ijpds-4052	88	3	classified	classify	VERB
ijpds-4052	88	4	as	as	ADP
ijpds-4052	88	5	a	a	DET
ijpds-4052	88	6	conditional	conditional	ADJ
ijpds-4052	88	7	recommendation	recommendation	NOUN
ijpds-4052	88	8	with	with	ADP
ijpds-4052	88	9	extremely	extremely	ADV
ijpds-4052	88	10	low	low	ADJ
ijpds-4052	88	11	assurance	assurance	NOUN
ijpds-4052	88	12	in	in	ADP
ijpds-4052	88	13	the	the	DET
ijpds-4052	88	14	estimate	estimate	NOUN
ijpds-4052	88	15	of	of	ADP
ijpds-4052	88	16	the	the	DET
ijpds-4052	88	17	effect	effect	NOUN
ijpds-4052	88	18	that	that	SCONJ
ijpds-4052	88	19	name	name	NOUN
ijpds-4052	88	20	of	of	ADP
ijpds-4052	88	21	the	the	DET
ijpds-4052	88	22	test	test	NOUN
ijpds-4052	88	23	day	day	NOUN
ijpds-4052	88	24	2	2	NUM
ijpds-4052	88	25	day	day	NOUN
ijpds-4052	88	26	5	5	NUM
ijpds-4052	88	27	day	day	NOUN
ijpds-4052	88	28	10	10	NUM
ijpds-4052	88	29	serum	serum	NOUN
ijpds-4052	88	30	bilirubin	bilirubin	NOUN
ijpds-4052	88	31	(	(	PUNCT
ijpds-4052	88	32	0.2	0.2	NUM
ijpds-4052	88	33	-	-	SYM
ijpds-4052	88	34	1	1	NUM
ijpds-4052	88	35	mg	mg	PROPN
ijpds-4052	88	36	/	/	SYM
ijpds-4052	88	37	dl	dl	NOUN
ijpds-4052	88	38	)	)	PUNCT
ijpds-4052	88	39	4.6	4.6	NUM
ijpds-4052	88	40	7.4	7.4	NUM
ijpds-4052	88	41	2.7	2.7	NUM
ijpds-4052	88	42	direct	direct	ADJ
ijpds-4052	88	43	bilirubin	bilirubin	NOUN
ijpds-4052	88	44	(	(	PUNCT
ijpds-4052	88	45	0	0	NUM
ijpds-4052	88	46	-	-	SYM
ijpds-4052	88	47	0.2	0.2	NUM
ijpds-4052	88	48	mg	mg	PROPN
ijpds-4052	88	49	/	/	SYM
ijpds-4052	88	50	dl	dl	NOUN
ijpds-4052	88	51	)	)	PUNCT
ijpds-4052	88	52	3.5	3.5	NUM
ijpds-4052	88	53	1.9	1.9	NUM
ijpds-4052	88	54	1.4	1.4	NUM
ijpds-4052	88	55	indirect	indirect	ADJ
ijpds-4052	88	56	bilirubin	bilirubin	NOUN
ijpds-4052	88	57	(	(	PUNCT
ijpds-4052	88	58	0.3	0.3	NUM
ijpds-4052	88	59	-	-	SYM
ijpds-4052	88	60	1.0	1.0	NUM
ijpds-4052	88	61	mg	mg	PROPN
ijpds-4052	88	62	/	/	SYM
ijpds-4052	88	63	dl	dl	PROPN
ijpds-4052	88	64	)	)	PUNCT
ijpds-4052	88	65	1.9	1.9	NUM
ijpds-4052	88	66	3.0	3.0	NUM
ijpds-4052	88	67	1.4	1.4	NUM
ijpds-4052	88	68	sr	sr	PROPN
ijpds-4052	88	69	.	.	PUNCT
ijpds-4052	89	1	total	total	ADJ
ijpds-4052	89	2	protein	protein	NOUN
ijpds-4052	89	3	(	(	PUNCT
ijpds-4052	89	4	6	6	NUM
ijpds-4052	89	5	-	-	SYM
ijpds-4052	89	6	8	8	NUM
ijpds-4052	89	7	g	g	PROPN
ijpds-4052	89	8	/	/	SYM
ijpds-4052	89	9	dl	dl	NOUN
ijpds-4052	89	10	)	)	PUNCT
ijpds-4052	89	11	5.6	5.6	NUM
ijpds-4052	89	12	7.2	7.2	NUM
ijpds-4052	89	13	7.9	7.9	NUM
ijpds-4052	89	14	albumin	albumin	NOUN
ijpds-4052	89	15	(	(	PUNCT
ijpds-4052	89	16	3.4	3.4	NUM
ijpds-4052	89	17	-	-	SYM
ijpds-4052	89	18	5.4	5.4	NUM
ijpds-4052	89	19	g	g	PROPN
ijpds-4052	89	20	/	/	SYM
ijpds-4052	89	21	dl	dl	NOUN
ijpds-4052	89	22	)	)	PUNCT
ijpds-4052	89	23	2.9	2.9	NUM
ijpds-4052	89	24	3.0	3.0	NUM
ijpds-4052	89	25	3.9	3.9	NUM
ijpds-4052	89	26	globulin	globulin	NOUN
ijpds-4052	89	27	(	(	PUNCT
ijpds-4052	89	28	2	2	NUM
ijpds-4052	89	29	-	-	SYM
ijpds-4052	89	30	3.5	3.5	NUM
ijpds-4052	89	31	g	g	NOUN
ijpds-4052	89	32	/	/	SYM
ijpds-4052	89	33	dl	dl	NOUN
ijpds-4052	89	34	)	)	PUNCT
ijpds-4052	89	35	3.0	3.0	NUM
ijpds-4052	89	36	4.0	4.0	NUM
ijpds-4052	89	37	2.4	2.4	NUM
ijpds-4052	89	38	s.g.o.t	s.g.o.t	PROPN
ijpds-4052	89	39	(	(	PUNCT
ijpds-4052	89	40	4	4	NUM
ijpds-4052	89	41	-	-	SYM
ijpds-4052	89	42	17	17	NUM
ijpds-4052	89	43	iu	iu	PROPN
ijpds-4052	89	44	/	/	SYM
ijpds-4052	89	45	l	l	NOUN
ijpds-4052	89	46	)	)	PUNCT
ijpds-4052	89	47	671.8	671.8	NUM
ijpds-4052	89	48	165	165	NUM
ijpds-4052	89	49	19	19	NUM
ijpds-4052	89	50	s.g.p.t	s.g.p.t	PROPN
ijpds-4052	89	51	(	(	PUNCT
ijpds-4052	89	52	3	3	NUM
ijpds-4052	89	53	-	-	SYM
ijpds-4052	89	54	5	5	NUM
ijpds-4052	89	55	iu	iu	NOUN
ijpds-4052	89	56	/	/	SYM
ijpds-4052	89	57	l	l	NOUN
ijpds-4052	89	58	)	)	PUNCT
ijpds-4052	89	59	132.9	132.9	NUM
ijpds-4052	89	60	50	50	NUM
ijpds-4052	89	61	18	18	NUM
ijpds-4052	89	62	alkaline	alkaline	NOUN
ijpds-4052	89	63	phosphatase	phosphatase	NOUN
ijpds-4052	89	64	(	(	PUNCT
ijpds-4052	89	65	44	44	NUM
ijpds-4052	89	66	-	-	SYM
ijpds-4052	89	67	147	147	NUM
ijpds-4052	89	68	iu	iu	PROPN
ijpds-4052	89	69	/	/	SYM
ijpds-4052	89	70	l	l	NOUN
ijpds-4052	89	71	)	)	PUNCT
ijpds-4052	89	72	136.4	136.4	NUM
ijpds-4052	89	73	104	104	NUM
ijpds-4052	89	74	90	90	NUM
ijpds-4052	89	75	bhui	bhui	NOUN
ijpds-4052	89	76	u	u	PROPN
ijpds-4052	89	77	et	et	PROPN
ijpds-4052	89	78	al	al	PROPN
ijpds-4052	89	79	.	.	PUNCT
ijpds-4052	90	1	anti	anti	ADJ
ijpds-4052	90	2	-	-	ADJ
ijpds-4052	90	3	tubercular	tubercular	ADJ
ijpds-4052	90	4	drug	drug	NOUN
ijpds-4052	90	5	-	-	PUNCT
ijpds-4052	90	6	induced	induce	VERB
ijpds-4052	90	7	vitamin	vitamin	NOUN
ijpds-4052	90	8	b6	b6	NOUN
ijpds-4052	90	9	deficiency	deficiency	NOUN
ijpds-4052	90	10	vol	vol	NOUN
ijpds-4052	90	11	2	2	NUM
ijpds-4052	90	12	|	|	NOUN
ijpds-4052	90	13	issue	issue	VERB
ijpds-4052	90	14	3	3	NUM
ijpds-4052	90	15	|	|	ADV
ijpds-4052	90	16	jul	jul	PROPN
ijpds-4052	90	17	–	–	PUNCT
ijpds-4052	90	18	sep	sep	PROPN
ijpds-4052	90	19	2023	2023	NUM
ijpds-4052	90	20	indian	indian	PROPN
ijpds-4052	90	21	j	j	PROPN
ijpds-4052	90	22	pharm	pharm	PROPN
ijpds-4052	90	23	drug	drug	PROPN
ijpds-4052	90	24	studies	study	NOUN
ijpds-4052	90	25	|	|	ADV
ijpds-4052	90	26	126	126	NUM
ijpds-4052	90	27	the	the	DET
ijpds-4052	90	28	recent	recent	ADJ
ijpds-4052	90	29	who	who	PRON
ijpds-4052	90	30	moves	move	VERB
ijpds-4052	90	31	to	to	PART
ijpds-4052	90	32	prescribe	prescribe	VERB
ijpds-4052	90	33	at	at	ADV
ijpds-4052	90	34	least	least	ADV
ijpds-4052	90	35	4	4	NUM
ijpds-4052	90	36	effective	effective	ADJ
ijpds-4052	90	37	medications	medication	NOUN
ijpds-4052	90	38	at	at	ADP
ijpds-4052	90	39	the	the	DET
ijpds-4052	90	40	beginning	beginning	NOUN
ijpds-4052	90	41	of	of	ADP
ijpds-4052	90	42	treatment	treatment	NOUN
ijpds-4052	90	43	is	be	AUX
ijpds-4052	90	44	effective	effective	ADJ
ijpds-4052	90	45	.	.	PUNCT
ijpds-4052	91	1	note	note	VERB
ijpds-4052	91	2	that	that	SCONJ
ijpds-4052	91	3	the	the	DET
ijpds-4052	91	4	2019	2019	NUM
ijpds-4052	91	5	who	who	PRON
ijpds-4052	91	6	guidelines	guideline	VERB
ijpds-4052	91	7	and	and	CCONJ
ijpds-4052	91	8	our	our	PRON
ijpds-4052	91	9	guideline	guideline	NOUN
ijpds-4052	91	10	committee	committee	NOUN
ijpds-4052	91	11	both	both	CCONJ
ijpds-4052	91	12	promote	promote	VERB
ijpds-4052	91	13	the	the	DET
ijpds-4052	91	14	use	use	NOUN
ijpds-4052	91	15	of	of	ADP
ijpds-4052	91	16	newer	new	ADJ
ijpds-4052	91	17	,	,	PUNCT
ijpds-4052	91	18	more	more	ADV
ijpds-4052	91	19	effective	effective	ADJ
ijpds-4052	91	20	oral	oral	ADJ
ijpds-4052	91	21	medicines	medicine	NOUN
ijpds-4052	91	22	with	with	ADP
ijpds-4052	91	23	better	well	ADJ
ijpds-4052	91	24	repurposing	repurpose	VERB
ijpds-4052	91	25	and	and	CCONJ
ijpds-4052	91	26	downplay	downplay	VERB
ijpds-4052	91	27	the	the	DET
ijpds-4052	91	28	use	use	NOUN
ijpds-4052	91	29	of	of	ADP
ijpds-4052	91	30	injectable	injectable	ADJ
ijpds-4052	91	31	treatments	treatment	NOUN
ijpds-4052	91	32	[	[	X
ijpds-4052	91	33	8	8	NUM
ijpds-4052	91	34	]	]	PUNCT
ijpds-4052	91	35	.	.	PUNCT
ijpds-4052	92	1	the	the	DET
ijpds-4052	92	2	new	new	ADJ
ijpds-4052	92	3	who	who	PRON
ijpds-4052	92	4	recommendation	recommendation	VERB
ijpds-4052	92	5	for	for	ADP
ijpds-4052	92	6	the	the	DET
ijpds-4052	92	7	previous	previous	ADJ
ijpds-4052	92	8	approach	approach	NOUN
ijpds-4052	92	9	is	be	AUX
ijpds-4052	92	10	multidrug	multidrug	NOUN
ijpds-4052	92	11	-	-	PUNCT
ijpds-4052	92	12	resistant	resistant	ADJ
ijpds-4052	92	13	tb	tb	X
ijpds-4052	92	14	(	(	PUNCT
ijpds-4052	92	15	mdr	mdr	PROPN
ijpds-4052	92	16	-	-	NOUN
ijpds-4052	92	17	tb	tb	NOUN
ijpds-4052	92	18	)	)	PUNCT
ijpds-4052	92	19	and	and	CCONJ
ijpds-4052	92	20	are	be	AUX
ijpds-4052	92	21	rifampin	rifampin	NOUN
ijpds-4052	92	22	resistance	resistance	NOUN
ijpds-4052	92	23	tb	tb	NOUN
ijpds-4052	92	24	(	(	PUNCT
ijpds-4052	92	25	rr	rr	NOUN
ijpds-4052	92	26	-	-	PUNCT
ijpds-4052	92	27	tb	tb	NOUN
ijpds-4052	92	28	)	)	PUNCT
ijpds-4052	92	29	in	in	ADP
ijpds-4052	92	30	several	several	ADJ
ijpds-4052	92	31	regards	regard	NOUN
ijpds-4052	92	32	;	;	PUNCT
ijpds-4052	92	33	levofloxacin	levofloxacin	NOUN
ijpds-4052	92	34	or	or	CCONJ
ijpds-4052	92	35	moxifloxacin	moxifloxacin	NOUN
ijpds-4052	92	36	may	may	AUX
ijpds-4052	92	37	be	be	AUX
ijpds-4052	92	38	used	use	VERB
ijpds-4052	92	39	.	.	PUNCT
ijpds-4052	93	1	for	for	ADP
ijpds-4052	93	2	fluoroquinolone	fluoroquinolone	NOUN
ijpds-4052	93	3	,	,	PUNCT
ijpds-4052	93	4	levofloxacin	levofloxacin	PROPN
ijpds-4052	93	5	is	be	AUX
ijpds-4052	93	6	advised	advise	VERB
ijpds-4052	93	7	because	because	SCONJ
ijpds-4052	93	8	to	to	ADP
ijpds-4052	93	9	its	its	PRON
ijpds-4052	93	10	safety	safety	NOUN
ijpds-4052	93	11	profile	profile	NOUN
ijpds-4052	93	12	and	and	CCONJ
ijpds-4052	93	13	lower	low	ADJ
ijpds-4052	93	14	risk	risk	NOUN
ijpds-4052	93	15	of	of	ADP
ijpds-4052	93	16	medication	medication	NOUN
ijpds-4052	93	17	interactions	interaction	NOUN
ijpds-4052	93	18	[	[	X
ijpds-4052	93	19	9	9	NUM
ijpds-4052	93	20	]	]	PUNCT
ijpds-4052	93	21	.	.	PUNCT
ijpds-4052	94	1	isoniazid	isoniazid	NOUN
ijpds-4052	94	2	can	can	AUX
ijpds-4052	94	3	cause	cause	VERB
ijpds-4052	94	4	various	various	ADJ
ijpds-4052	94	5	adverse	adverse	ADJ
ijpds-4052	94	6	events	event	NOUN
ijpds-4052	94	7	.	.	PUNCT
ijpds-4052	95	1	central	central	ADJ
ijpds-4052	95	2	nervous	nervous	ADJ
ijpds-4052	95	3	system	system	NOUN
ijpds-4052	95	4	(	(	PUNCT
ijpds-4052	95	5	cns	cns	NOUN
ijpds-4052	95	6	)	)	PUNCT
ijpds-4052	95	7	effects	effect	NOUN
ijpds-4052	95	8	,	,	PUNCT
ijpds-4052	95	9	such	such	ADJ
ijpds-4052	95	10	as	as	ADP
ijpds-4052	95	11	headache	headache	NOUN
ijpds-4052	95	12	seizure	seizure	NOUN
ijpds-4052	95	13	,	,	PUNCT
ijpds-4052	95	14	dysphoria	dysphoria	NOUN
ijpds-4052	95	15	,	,	PUNCT
ijpds-4052	95	16	and	and	CCONJ
ijpds-4052	95	17	irritability	irritability	NOUN
ijpds-4052	95	18	,	,	PUNCT
ijpds-4052	95	19	have	have	AUX
ijpds-4052	95	20	been	be	AUX
ijpds-4052	95	21	reported	report	VERB
ijpds-4052	95	22	.	.	PUNCT
ijpds-4052	96	1	cns	cns	PROPN
ijpds-4052	96	2	effects	effect	NOUN
ijpds-4052	96	3	occur	occur	VERB
ijpds-4052	96	4	due	due	ADJ
ijpds-4052	96	5	to	to	ADP
ijpds-4052	96	6	vitamin	vitamin	NOUN
ijpds-4052	96	7	b-6	b-6	NOUN
ijpds-4052	96	8	deficiency	deficiency	NOUN
ijpds-4052	96	9	;	;	PUNCT
ijpds-4052	96	10	in	in	ADP
ijpds-4052	96	11	the	the	DET
ijpds-4052	96	12	patient	patient	NOUN
ijpds-4052	96	13	's	's	PART
ijpds-4052	96	14	case	case	NOUN
ijpds-4052	96	15	,	,	PUNCT
ijpds-4052	96	16	a	a	DET
ijpds-4052	96	17	deficiency	deficiency	NOUN
ijpds-4052	96	18	of	of	ADP
ijpds-4052	96	19	vitamin	vitamin	NOUN
ijpds-4052	96	20	b-6	b-6	NOUN
ijpds-4052	96	21	of	of	ADP
ijpds-4052	96	22	regarded	regard	VERB
ijpds-4052	96	23	to	to	PART
ijpds-4052	96	24	be	be	AUX
ijpds-4052	96	25	a	a	DET
ijpds-4052	96	26	cause	cause	NOUN
ijpds-4052	96	27	of	of	ADP
ijpds-4052	96	28	patient	patient	ADJ
ijpds-4052	96	29	convulsions	convulsion	NOUN
ijpds-4052	96	30	and	and	CCONJ
ijpds-4052	96	31	seizures	seizure	NOUN
ijpds-4052	96	32	because	because	SCONJ
ijpds-4052	96	33	the	the	DET
ijpds-4052	96	34	serum	serum	NOUN
ijpds-4052	96	35	vitamin	vitamin	NOUN
ijpds-4052	96	36	b-6	b-6	NOUN
ijpds-4052	96	37	level	level	NOUN
ijpds-4052	96	38	was	be	AUX
ijpds-4052	96	39	administration	administration	NOUN
ijpds-4052	96	40	was	be	AUX
ijpds-4052	96	41	low	low	ADJ
ijpds-4052	97	1	[	[	X
ijpds-4052	97	2	10	10	NUM
ijpds-4052	97	3	]	]	PUNCT
ijpds-4052	97	4	.	.	PUNCT
ijpds-4052	98	1	conclusion	conclusion	NOUN
ijpds-4052	98	2	the	the	DET
ijpds-4052	98	3	case	case	NOUN
ijpds-4052	98	4	is	be	AUX
ijpds-4052	98	5	unique	unique	ADJ
ijpds-4052	98	6	because	because	SCONJ
ijpds-4052	98	7	the	the	DET
ijpds-4052	98	8	patient	patient	NOUN
ijpds-4052	98	9	developed	develop	VERB
ijpds-4052	98	10	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	98	11	and	and	CCONJ
ijpds-4052	98	12	convulsion	convulsion	NOUN
ijpds-4052	98	13	seizures	seizure	NOUN
ijpds-4052	98	14	due	due	ADJ
ijpds-4052	98	15	to	to	ADP
ijpds-4052	98	16	an	an	DET
ijpds-4052	98	17	adverse	adverse	ADJ
ijpds-4052	98	18	drug	drug	NOUN
ijpds-4052	98	19	reaction	reaction	NOUN
ijpds-4052	98	20	of	of	ADP
ijpds-4052	98	21	cat	cat	NOUN
ijpds-4052	98	22	1	1	NUM
ijpds-4052	98	23	atd	atd	PROPN
ijpds-4052	98	24	.	.	PUNCT
ijpds-4052	99	1	the	the	DET
ijpds-4052	99	2	supplementation	supplementation	NOUN
ijpds-4052	99	3	of	of	ADP
ijpds-4052	99	4	vitamin	vitamin	NOUN
ijpds-4052	99	5	b-6	b-6	NOUN
ijpds-4052	99	6	is	be	AUX
ijpds-4052	99	7	recommended	recommend	VERB
ijpds-4052	99	8	in	in	ADP
ijpds-4052	99	9	patients	patient	NOUN
ijpds-4052	99	10	with	with	ADP
ijpds-4052	99	11	other	other	ADJ
ijpds-4052	99	12	conditions	condition	NOUN
ijpds-4052	99	13	indicative	indicative	ADJ
ijpds-4052	99	14	of	of	ADP
ijpds-4052	99	15	subclinical	subclinical	ADJ
ijpds-4052	99	16	vitamin	vitamin	NOUN
ijpds-4052	99	17	b-6	b-6	NOUN
ijpds-4052	99	18	deficiency	deficiency	NOUN
ijpds-4052	99	19	to	to	PART
ijpds-4052	99	20	prevent	prevent	VERB
ijpds-4052	99	21	the	the	DET
ijpds-4052	99	22	central	central	ADJ
ijpds-4052	99	23	nervous	nervous	ADJ
ijpds-4052	99	24	system	system	NOUN
ijpds-4052	99	25	effect	effect	NOUN
ijpds-4052	99	26	.	.	PUNCT
ijpds-4052	100	1	the	the	DET
ijpds-4052	100	2	patient	patient	NOUN
ijpds-4052	100	3	was	be	AUX
ijpds-4052	100	4	diagnosed	diagnose	VERB
ijpds-4052	100	5	with	with	ADP
ijpds-4052	100	6	pulmonary	pulmonary	PROPN
ijpds-4052	100	7	koch	koch	PROPN
ijpds-4052	100	8	’s	’s	PART
ijpds-4052	100	9	infection	infection	NOUN
ijpds-4052	100	10	,	,	PUNCT
ijpds-4052	100	11	where	where	SCONJ
ijpds-4052	100	12	standard	standard	ADJ
ijpds-4052	100	13	treatments	treatment	NOUN
ijpds-4052	100	14	are	be	AUX
ijpds-4052	100	15	provided	provide	VERB
ijpds-4052	100	16	to	to	ADP
ijpds-4052	100	17	a	a	DET
ijpds-4052	100	18	patient	patient	NOUN
ijpds-4052	100	19	to	to	PART
ijpds-4052	100	20	reduce	reduce	VERB
ijpds-4052	100	21	the	the	DET
ijpds-4052	100	22	level	level	NOUN
ijpds-4052	100	23	of	of	ADP
ijpds-4052	100	24	alt	alt	ADJ
ijpds-4052	100	25	/	/	SYM
ijpds-4052	100	26	ast	ast	NOUN
ijpds-4052	100	27	.	.	PUNCT
ijpds-4052	101	1	clinical	clinical	ADJ
ijpds-4052	101	2	advancements	advancement	NOUN
ijpds-4052	101	3	and	and	CCONJ
ijpds-4052	101	4	positive	positive	ADJ
ijpds-4052	101	5	patient	patient	NOUN
ijpds-4052	101	6	outcomes	outcome	NOUN
ijpds-4052	101	7	are	be	AUX
ijpds-4052	101	8	future	future	ADJ
ijpds-4052	101	9	goals	goal	NOUN
ijpds-4052	101	10	that	that	PRON
ijpds-4052	101	11	we	we	PRON
ijpds-4052	101	12	can	can	AUX
ijpds-4052	101	13	accomplish	accomplish	VERB
ijpds-4052	101	14	.	.	PUNCT
ijpds-4052	102	1	references	reference	NOUN
ijpds-4052	102	2	1	1	NUM
ijpds-4052	102	3	.	.	PUNCT
ijpds-4052	103	1	tuberculosis	tuberculosis	NOUN
ijpds-4052	103	2	symptoms	symptom	NOUN
ijpds-4052	103	3	,	,	PUNCT
ijpds-4052	103	4	and	and	CCONJ
ijpds-4052	103	5	causes	cause	VERB
ijpds-4052	104	1	[	[	X
ijpds-4052	104	2	internet	internet	NOUN
ijpds-4052	104	3	]	]	PUNCT
ijpds-4052	104	4	.	.	PUNCT
ijpds-4052	105	1	mayo	mayo	PROPN
ijpds-4052	105	2	clinic	clinic	PROPN
ijpds-4052	105	3	publications	publication	NOUN
ijpds-4052	105	4	;	;	PUNCT
ijpds-4052	105	5	2021	2021	NUM
ijpds-4052	105	6	[	[	X
ijpds-4052	105	7	cited	cite	VERB
ijpds-4052	105	8	22	22	NUM
ijpds-4052	105	9	march	march	NOUN
ijpds-4052	105	10	2023	2023	NUM
ijpds-4052	105	11	]	]	PUNCT
ijpds-4052	105	12	.	.	PUNCT
ijpds-4052	106	1	available	available	ADJ
ijpds-4052	106	2	from	from	ADP
ijpds-4052	106	3	:	:	PUNCT
ijpds-4052	106	4	https://www.mayoclinic.org/diseasesconditions/tuberculosis/s	https://www.mayoclinic.org/diseasesconditions/tuberculosis/s	PROPN
ijpds-4052	106	5	ymptoms	ymptom	NOUN
ijpds-4052	106	6	-	-	PUNCT
ijpds-4052	106	7	causes	cause	NOUN
ijpds-4052	106	8	/	/	SYM
ijpds-4052	106	9	syc-20351250	syc-20351250	NOUN
ijpds-4052	106	10	.	.	PUNCT
ijpds-4052	107	1	2	2	X
ijpds-4052	107	2	.	.	X
ijpds-4052	107	3	tesfahuneygn	tesfahuneygn	PROPN
ijpds-4052	107	4	g	g	PROPN
ijpds-4052	107	5	,	,	PUNCT
ijpds-4052	107	6	medhin	medhin	NOUN
ijpds-4052	107	7	g	g	NOUN
ijpds-4052	107	8	,	,	PUNCT
ijpds-4052	107	9	legesse	legesse	NOUN
ijpds-4052	107	10	m.	m.	NOUN
ijpds-4052	107	11	adherence	adherence	NOUN
ijpds-4052	107	12	to	to	AUX
ijpds-4052	107	13	antituberculosis	antituberculosis	VERB
ijpds-4052	107	14	treatment	treatment	NOUN
ijpds-4052	107	15	and	and	CCONJ
ijpds-4052	107	16	treatment	treatment	NOUN
ijpds-4052	107	17	outcomes	outcome	NOUN
ijpds-4052	107	18	among	among	ADP
ijpds-4052	107	19	tuberculosis	tuberculosis	NOUN
ijpds-4052	107	20	patients	patient	NOUN
ijpds-4052	107	21	in	in	ADP
ijpds-4052	107	22	alamata	alamata	PROPN
ijpds-4052	107	23	district	district	NOUN
ijpds-4052	107	24	,	,	PUNCT
ijpds-4052	107	25	northeast	northeast	ADJ
ijpds-4052	107	26	ethiopia	ethiopia	PROPN
ijpds-4052	107	27	.	.	PUNCT
ijpds-4052	108	1	bmc	bmc	ADJ
ijpds-4052	108	2	res	re	NOUN
ijpds-4052	108	3	notes	note	NOUN
ijpds-4052	108	4	.	.	PUNCT
ijpds-4052	109	1	2015;8(1):503	2015;8(1):503	X
ijpds-4052	109	2	.	.	PUNCT
ijpds-4052	110	1	doi	doi	NOUN
ijpds-4052	110	2	:	:	PUNCT
ijpds-4052	110	3	10.1186/	10.1186/	NUM
ijpds-4052	110	4	s13104	s13104	PROPN
ijpds-4052	110	5	-	-	PUNCT
ijpds-4052	110	6	0151452	0151452	NUM
ijpds-4052	110	7	-	-	SYM
ijpds-4052	110	8	x	x	NOUN
ijpds-4052	110	9	,	,	PUNCT
ijpds-4052	110	10	pmid	pmid	PROPN
ijpds-4052	110	11	26420164	26420164	NUM
ijpds-4052	110	12	.	.	PUNCT
ijpds-4052	111	1	3	3	X
ijpds-4052	111	2	.	.	X
ijpds-4052	111	3	center	center	NOUN
ijpds-4052	111	4	for	for	ADP
ijpds-4052	111	5	global	global	ADJ
ijpds-4052	111	6	health	health	NOUN
ijpds-4052	111	7	stories	story	NOUN
ijpds-4052	111	8	of	of	ADP
ijpds-4052	111	9	hope	hope	NOUN
ijpds-4052	111	10	sorted	sort	VERB
ijpds-4052	111	11	by	by	ADP
ijpds-4052	111	12	date	date	NOUN
ijpds-4052	111	13	[	[	X
ijpds-4052	111	14	internet	internet	NOUN
ijpds-4052	111	15	]	]	X
ijpds-4052	111	16	;	;	PUNCT
ijpds-4052	111	17	2021[cited	2021[cite	VERB
ijpds-4052	111	18	16	16	NUM
ijpds-4052	111	19	may	may	PROPN
ijpds-4052	111	20	2023	2023	NUM
ijpds-4052	111	21	]	]	PUNCT
ijpds-4052	111	22	.	.	PUNCT
ijpds-4052	112	1	available	available	ADJ
ijpds-4052	112	2	from	from	ADP
ijpds-4052	112	3	:	:	PUNCT
ijpds-4052	112	4	https://www.cdc.gov/globalhealth/	https://www.cdc.gov/globalhealth/	NUM
ijpds-4052	112	5	stories	story	NOUN
ijpds-4052	112	6	/	/	SYM
ijpds-4052	112	7	date	date	NOUN
ijpds-4052	112	8	-	-	PUNCT
ijpds-4052	112	9	list.html	list.html	NOUN
ijpds-4052	112	10	.	.	NOUN
ijpds-4052	113	1	4	4	X
ijpds-4052	113	2	.	.	X
ijpds-4052	113	3	khan	khan	PROPN
ijpds-4052	113	4	ms	ms	PROPN
ijpds-4052	113	5	,	,	PUNCT
ijpds-4052	113	6	sunny	sunny	ADJ
ijpds-4052	113	7	b	b	NOUN
ijpds-4052	113	8	,	,	PUNCT
ijpds-4052	113	9	krishnan	krishnan	PROPN
ijpds-4052	113	10	rm	rm	PROPN
ijpds-4052	113	11	.	.	PUNCT
ijpds-4052	114	1	case	case	NOUN
ijpds-4052	114	2	report	report	NOUN
ijpds-4052	114	3	on	on	ADP
ijpds-4052	114	4	antitubercular	antitubercular	ADJ
ijpds-4052	114	5	drug	drug	NOUN
ijpds-4052	114	6	induced	induce	VERB
ijpds-4052	114	7	hepatoxicity	hepatoxicity	NOUN
ijpds-4052	114	8	/	/	SYM
ijpds-4052	114	9	modified	modify	VERB
ijpds-4052	114	10	att	att	PROPN
ijpds-4052	114	11	.	.	PUNCT
ijpds-4052	115	1	indian	indian	PROPN
ijpds-4052	115	2	journal	journal	PROPN
ijpds-4052	115	3	of	of	ADP
ijpds-4052	115	4	pharmacy	pharmacy	NOUN
ijpds-4052	115	5	practice	practice	NOUN
ijpds-4052	115	6	.	.	PUNCT
ijpds-4052	116	1	2021;14(4	2021;14(4	NUM
ijpds-4052	116	2	)	)	PUNCT
ijpds-4052	116	3	.	.	PUNCT
ijpds-4052	117	1	5	5	X
ijpds-4052	117	2	.	.	X
ijpds-4052	117	3	tost	tost	PROPN
ijpds-4052	117	4	jr	jr	PROPN
ijpds-4052	117	5	,	,	PUNCT
ijpds-4052	117	6	vidal	vidal	PROPN
ijpds-4052	117	7	r	r	NOUN
ijpds-4052	117	8	,	,	PUNCT
ijpds-4052	117	9	caylà	caylà	NOUN
ijpds-4052	117	10	j	j	PROPN
ijpds-4052	117	11	,	,	PUNCT
ijpds-4052	117	12	et	et	PROPN
ijpds-4052	117	13	al	al	PROPN
ijpds-4052	117	14	.	.	PROPN
ijpds-4052	117	15	study	study	PROPN
ijpds-4052	117	16	group	group	NOUN
ijpds-4052	117	17	for	for	ADP
ijpds-4052	117	18	severe	severe	ADJ
ijpds-4052	117	19	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	117	20	due	due	ADP
ijpds-4052	117	21	to	to	ADP
ijpds-4052	117	22	anti	anti	ADJ
ijpds-4052	117	23	-	-	ADJ
ijpds-4052	117	24	tuberculosis	tuberculosis	ADJ
ijpds-4052	117	25	drugs	drug	NOUN
ijpds-4052	117	26	and	and	CCONJ
ijpds-4052	117	27	the	the	DET
ijpds-4052	117	28	study	study	NOUN
ijpds-4052	117	29	group	group	NOUN
ijpds-4052	117	30	for	for	ADP
ijpds-4052	117	31	severe	severe	ADJ
ijpds-4052	117	32	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	117	33	.	.	PUNCT
ijpds-4052	118	1	severe	severe	ADJ
ijpds-4052	118	2	hepatotoxicity	hepatotoxicity	NOUN
ijpds-4052	118	3	due	due	ADP
ijpds-4052	118	4	to	to	ADP
ijpds-4052	118	5	anti	anti	ADJ
ijpds-4052	118	6	-	-	ADJ
ijpds-4052	118	7	tuberculosis	tuberculosis	ADJ
ijpds-4052	118	8	drugs	drug	NOUN
ijpds-4052	118	9	in	in	ADP
ijpds-4052	118	10	spain	spain	PROPN
ijpds-4052	118	11	.	.	PUNCT
ijpds-4052	119	1	int	int	PROPN
ijpds-4052	119	2	j	j	PROPN
ijpds-4052	119	3	tuberc	tuberc	PROPN
ijpds-4052	119	4	lung	lung	PROPN
ijpds-4052	119	5	dis	dis	PROPN
ijpds-4052	119	6	.	.	PUNCT
ijpds-4052	120	1	2005;9(5):534	2005;9(5):534	NUM
ijpds-4052	120	2	-	-	SYM
ijpds-4052	120	3	40	40	NUM
ijpds-4052	120	4	.	.	PUNCT
ijpds-4052	121	1	pmid	pmid	NOUN
ijpds-4052	121	2	15875925	15875925	NUM
ijpds-4052	121	3	.	.	PUNCT
ijpds-4052	122	1	6	6	NUM
ijpds-4052	122	2	.	.	PUNCT
ijpds-4052	123	1	nahid	nahid	PROPN
ijpds-4052	123	2	p	p	PROPN
ijpds-4052	123	3	,	,	PUNCT
ijpds-4052	123	4	mase	mase	PROPN
ijpds-4052	123	5	sr	sr	PROPN
ijpds-4052	123	6	,	,	PUNCT
ijpds-4052	123	7	migliori	migliori	PROPN
ijpds-4052	123	8	gb	gb	PROPN
ijpds-4052	123	9	,	,	PUNCT
ijpds-4052	123	10	et	et	PROPN
ijpds-4052	123	11	al	al	PROPN
ijpds-4052	123	12	.	.	PUNCT
ijpds-4052	124	1	treatment	treatment	NOUN
ijpds-4052	124	2	of	of	ADP
ijpds-4052	124	3	drugresistant	drugresistant	NOUN
ijpds-4052	124	4	tuberculosis	tuberculosis	NOUN
ijpds-4052	124	5	.	.	PUNCT
ijpds-4052	125	1	an	an	DET
ijpds-4052	125	2	official	official	ADJ
ijpds-4052	125	3	ats	ats	PROPN
ijpds-4052	125	4	/	/	SYM
ijpds-4052	125	5	cdc	cdc	PROPN
ijpds-4052	125	6	/	/	SYM
ijpds-4052	125	7	ers	ers	PROPN
ijpds-4052	125	8	/	/	SYM
ijpds-4052	125	9	idsa	idsa	NOUN
ijpds-4052	125	10	clinical	clinical	ADJ
ijpds-4052	125	11	practice	practice	NOUN
ijpds-4052	125	12	guideline	guideline	NOUN
ijpds-4052	125	13	.	.	PUNCT
ijpds-4052	126	1	am	be	AUX
ijpds-4052	126	2	jrespircrit	jrespircrit	PROPN
ijpds-4052	126	3	care	care	NOUN
ijpds-4052	126	4	med	me	VERB
ijpds-4052	126	5	.	.	PUNCT
ijpds-4052	126	6	2019	2019	NUM
ijpds-4052	126	7	;	;	PUNCT
ijpds-4052	126	8	200(10):e93	200(10):e93	NUM
ijpds-4052	126	9	-	-	SYM
ijpds-4052	126	10	e142	e142	PROPN
ijpds-4052	126	11	.	.	PROPN
ijpds-4052	126	12	7	7	NUM
ijpds-4052	126	13	.	.	X
ijpds-4052	127	1	mase	mase	PROPN
ijpds-4052	127	2	sr	sr	PROPN
ijpds-4052	127	3	,	,	PUNCT
ijpds-4052	127	4	chorba	chorba	NOUN
ijpds-4052	127	5	t.	t.	NOUN
ijpds-4052	127	6	treatment	treatment	NOUN
ijpds-4052	127	7	of	of	ADP
ijpds-4052	127	8	drug	drug	NOUN
ijpds-4052	127	9	-	-	PUNCT
ijpds-4052	127	10	resistant	resistant	ADJ
ijpds-4052	127	11	tuberculosis	tuberculosis	NOUN
ijpds-4052	127	12	.	.	PUNCT
ijpds-4052	128	1	clinics	clinic	NOUN
ijpds-4052	128	2	in	in	ADP
ijpds-4052	128	3	chest	chest	NOUN
ijpds-4052	128	4	medicine	medicine	NOUN
ijpds-4052	128	5	.	.	PUNCT
ijpds-4052	129	1	2019	2019	NUM
ijpds-4052	129	2	dec	dec	PROPN
ijpds-4052	129	3	1;40(4):775	1;40(4):775	NUM
ijpds-4052	129	4	-	-	SYM
ijpds-4052	129	5	95	95	NUM
ijpds-4052	129	6	.	.	NOUN
ijpds-4052	129	7	8	8	NUM
ijpds-4052	129	8	.	.	X
ijpds-4052	129	9	temmerman	temmerman	PROPN
ijpds-4052	129	10	w	w	PROPN
ijpds-4052	129	11	,	,	PUNCT
ijpds-4052	129	12	dhondt	dhondt	PROPN
ijpds-4052	129	13	a	a	PRON
ijpds-4052	129	14	,	,	PUNCT
ijpds-4052	129	15	vandewoude	vandewoude	ADJ
ijpds-4052	129	16	k.	k.	PROPN
ijpds-4052	129	17	acute	acute	PROPN
ijpds-4052	129	18	isoniazid	isoniazid	PROPN
ijpds-4052	129	19	intoxication	intoxication	NOUN
ijpds-4052	129	20	:	:	PUNCT
ijpds-4052	129	21	seizures	seizure	NOUN
ijpds-4052	129	22	,	,	PUNCT
ijpds-4052	129	23	acidosis	acidosis	NOUN
ijpds-4052	129	24	and	and	CCONJ
ijpds-4052	129	25	coma	coma	NOUN
ijpds-4052	129	26	.	.	PUNCT
ijpds-4052	130	1	acta	acta	PROPN
ijpds-4052	130	2	clin	clin	PROPN
ijpds-4052	130	3	belg	belg	PROPN
ijpds-4052	130	4	54	54	NUM
ijpds-4052	130	5	:	:	PUNCT
ijpds-4052	130	6	211	211	NUM
ijpds-4052	130	7	-	-	SYM
ijpds-4052	130	8	216	216	NUM
ijpds-4052	130	9	,	,	PUNCT
ijpds-4052	130	10	1999	1999	NUM
ijpds-4052	130	11	.	.	PUNCT
ijpds-4052	131	1	9	9	X
ijpds-4052	131	2	.	.	X
ijpds-4052	131	3	minns	minns	PROPN
ijpds-4052	131	4	ab	ab	PROPN
ijpds-4052	131	5	,	,	PUNCT
ijpds-4052	131	6	ghafouri	ghafouri	PROPN
ijpds-4052	131	7	n	n	PROPN
ijpds-4052	131	8	,	,	PUNCT
ijpds-4052	131	9	clark	clark	PROPN
ijpds-4052	131	10	rf	rf	PROPN
ijpds-4052	131	11	.	.	PROPN
ijpds-4052	131	12	isoniazid	isoniazid	NOUN
ijpds-4052	131	13	-	-	PUNCT
ijpds-4052	131	14	induced	induce	VERB
ijpds-4052	131	15	status	status	NOUN
ijpds-4052	131	16	epilepticus	epilepticus	VERB
ijpds-4052	131	17	in	in	ADP
ijpds-4052	131	18	a	a	DET
ijpds-4052	131	19	pediatric	pediatric	ADJ
ijpds-4052	131	20	patient	patient	NOUN
ijpds-4052	131	21	after	after	ADP
ijpds-4052	131	22	inadequate	inadequate	ADJ
ijpds-4052	131	23	pyridoxine	pyridoxine	NOUN
ijpds-4052	131	24	therapy	therapy	NOUN
ijpds-4052	131	25	.	.	PUNCT
ijpds-4052	132	1	pediatremerg	pediatremerg	PROPN
ijpds-4052	132	2	care	care	VERB
ijpds-4052	132	3	.	.	PUNCT
ijpds-4052	133	1	2010	2010	NUM
ijpds-4052	133	2	may;26(5):380	may;26(5):380	NOUN
ijpds-4052	133	3	-	-	SYM
ijpds-4052	133	4	1	1	NUM
ijpds-4052	133	5	.	.	NOUN
ijpds-4052	133	6	10	10	NUM
ijpds-4052	133	7	.	.	PUNCT
ijpds-4052	134	1	gokhale	gokhale	PROPN
ijpds-4052	134	2	ya	ya	PROPN
ijpds-4052	134	3	,	,	PUNCT
ijpds-4052	134	4	vaidya	vaidya	PROPN
ijpds-4052	134	5	ms	ms	PROPN
ijpds-4052	134	6	,	,	PUNCT
ijpds-4052	134	7	mehta	mehta	PROPN
ijpds-4052	134	8	ad	ad	NOUN
ijpds-4052	134	9	,	,	PUNCT
ijpds-4052	134	10	rathod	rathod	PROPN
ijpds-4052	134	11	nn	nn	PROPN
ijpds-4052	134	12	.	.	PROPN
ijpds-4052	134	13	isoniazid	isoniazid	PROPN
ijpds-4052	134	14	toxicity	toxicity	NOUN
ijpds-4052	134	15	presenting	presenting	NOUN
ijpds-4052	134	16	as	as	ADP
ijpds-4052	134	17	status	status	NOUN
ijpds-4052	134	18	epilepticus	epilepticus	NOUN
ijpds-4052	134	19	and	and	CCONJ
ijpds-4052	134	20	severe	severe	ADJ
ijpds-4052	134	21	metabolic	metabolic	NOUN
ijpds-4052	134	22	acidosis	acidosis	NOUN
ijpds-4052	134	23	.	.	PUNCT
ijpds-4052	135	1	j	j	PROPN
ijpds-4052	135	2	assoc	assoc	PROPN
ijpds-4052	135	3	physicians	physicians	PROPN
ijpds-4052	135	4	india	india	PROPN
ijpds-4052	135	5	.	.	PROPN
ijpds-4052	135	6	2009	2009	NUM
ijpds-4052	135	7	jan;57:70	jan;57:70	PROPN
ijpds-4052	135	8	-	-	PUNCT
ijpds-4052	135	9	1	1	NUM
ijpds-4052	135	10	.	.	PUNCT
ijpds-4052	136	1	how	how	SCONJ
ijpds-4052	136	2	to	to	PART
ijpds-4052	136	3	cite	cite	VERB
ijpds-4052	136	4	this	this	DET
ijpds-4052	136	5	article	article	NOUN
ijpds-4052	136	6	:	:	PUNCT
ijpds-4052	136	7	utpal	utpal	PROPN
ijpds-4052	136	8	bhui	bhui	PROPN
ijpds-4052	136	9	,	,	PUNCT
ijpds-4052	136	10	subhajit	subhajit	NOUN
ijpds-4052	136	11	sarkar	sarkar	NOUN
ijpds-4052	136	12	,	,	PUNCT
ijpds-4052	136	13	joy	joy	NOUN
ijpds-4052	136	14	das	das	PROPN
ijpds-4052	136	15	,	,	PUNCT
ijpds-4052	136	16	indra	indra	PROPN
ijpds-4052	136	17	kumar	kumar	PROPN
ijpds-4052	136	18	ghoshal	ghoshal	PROPN
ijpds-4052	136	19	,	,	PUNCT
ijpds-4052	136	20	abhik	abhik	PROPN
ijpds-4052	136	21	saha	saha	PROPN
ijpds-4052	136	22	,	,	PUNCT
ijpds-4052	136	23	bimlesh	bimlesh	PROPN
ijpds-4052	136	24	kumar	kumar	PROPN
ijpds-4052	136	25	.	.	PUNCT
ijpds-4052	137	1	unraveling	unravel	VERB
ijpds-4052	137	2	the	the	DET
ijpds-4052	137	3	enigma	enigma	NOUN
ijpds-4052	137	4	of	of	ADP
ijpds-4052	137	5	anti	anti	ADJ
ijpds-4052	137	6	-	-	ADJ
ijpds-4052	137	7	tubercular	tubercular	ADJ
ijpds-4052	137	8	drug	drug	NOUN
ijpds-4052	137	9	-	-	PUNCT
ijpds-4052	137	10	induced	induce	VERB
ijpds-4052	137	11	vitamin	vitamin	NOUN
ijpds-4052	137	12	b6	b6	NOUN
ijpds-4052	137	13	deficiency	deficiency	NOUN
ijpds-4052	137	14	and	and	CCONJ
ijpds-4052	137	15	its	its	PRON
ijpds-4052	137	16	role	role	NOUN
ijpds-4052	137	17	in	in	ADP
ijpds-4052	137	18	provoking	provoke	VERB
ijpds-4052	137	19	convulsive	convulsive	ADJ
ijpds-4052	137	20	seizures	seizure	NOUN
ijpds-4052	137	21	a	a	DET
ijpds-4052	137	22	revelatory	revelatory	ADJ
ijpds-4052	137	23	case	case	NOUN
ijpds-4052	137	24	report	report	NOUN
ijpds-4052	137	25	.	.	PUNCT
ijpds-4052	138	1	indian	indian	PROPN
ijpds-4052	138	2	j	j	PROPN
ijpds-4052	138	3	pharm	pharm	PROPN
ijpds-4052	138	4	drug	drug	PROPN
ijpds-4052	138	5	studies	study	NOUN
ijpds-4052	138	6	.	.	PUNCT
ijpds-4052	139	1	2023	2023	NUM
ijpds-4052	139	2	;	;	PUNCT
ijpds-4052	139	3	2(3	2(3	NUM
ijpds-4052	139	4	)	)	PUNCT
ijpds-4052	139	5	124126	124126	NUM
ijpds-4052	139	6	.	.	PUNCT
ijpds-4052	140	1	funding	funding	NOUN
ijpds-4052	140	2	:	:	PUNCT
ijpds-4052	140	3	none	none	NOUN
ijpds-4052	140	4	conflict	conflict	NOUN
ijpds-4052	140	5	of	of	ADP
ijpds-4052	140	6	interest	interest	NOUN
ijpds-4052	140	7	:	:	PUNCT
ijpds-4052	140	8	none	none	NOUN
ijpds-4052	140	9	stated	state	VERB
ijpds-4052	140	10	https://www.mayoclinic.org/diseasesconditions/tuberculosis/symptoms-causes/syc-20351250	https://www.mayoclinic.org/diseasesconditions/tuberculosis/symptoms-causes/syc-20351250	PROPN
ijpds-4052	140	11	https://www.mayoclinic.org/diseasesconditions/tuberculosis/symptoms-causes/syc-20351250	https://www.mayoclinic.org/diseasesconditions/tuberculosis/symptoms-causes/syc-20351250	PROPN